<?xml version="1.0" ?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.3 20210610//EN"  "JATS-archivearticle1-mathml3.dtd"><article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">elife</journal-id>
<journal-id journal-id-type="publisher-id">eLife</journal-id>
<journal-title-group>
<journal-title>eLife</journal-title>
</journal-title-group>
<issn publication-format="electronic" pub-type="epub">2050-084X</issn>
<publisher>
<publisher-name>eLife Sciences Publications, Ltd</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">105488</article-id>
<article-id pub-id-type="doi">10.7554/eLife.105488</article-id>
<article-id pub-id-type="doi" specific-use="version">10.7554/eLife.105488.1</article-id>
<article-version-alternatives>
<article-version article-version-type="publication-state">reviewed preprint</article-version>
<article-version article-version-type="preprint-version">1.1</article-version>
</article-version-alternatives>
<article-categories><subj-group subj-group-type="heading">
<subject>Medicine</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Epidemiology and Global Health</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Five-Year Survival Outcomes for Breast Cancer Patients Across Continental Africa: A Contemporary Review of Literature with Meta Analysis</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name>
<surname>Badu-Peprah</surname>
<given-names>Augustina</given-names>
</name>
<xref ref-type="aff" rid="a1">1</xref>
<xref ref-type="aff" rid="a2">2</xref>
<xref ref-type="author-notes" rid="n1">†</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" equal-contrib="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7349-8012</contrib-id>
<name>
<surname>Kontor</surname>
<given-names>Ernest Kissi</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
<email>ernestkissikontor@gmail.com</email>
<xref ref-type="author-notes" rid="n1">†</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Benjamin</surname>
<given-names>Adu-Gyamfi</given-names>
</name>
<xref ref-type="aff" rid="a2">2</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kumah</surname>
<given-names>Jessica</given-names>
</name>
<xref ref-type="aff" rid="a4">4</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Essuman</surname>
<given-names>Akosua Aya</given-names>
</name>
<xref ref-type="aff" rid="a5">5</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Selorm</surname>
<given-names>Bossoh</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nurudeen</surname>
<given-names>Issahak</given-names>
</name>
<xref ref-type="aff" rid="a3">3</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Owusu</surname>
<given-names>Bismark Osei</given-names>
</name>
<xref ref-type="aff" rid="a6">6</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7918-7909</contrib-id>
<name>
<surname>Jain</surname>
<given-names>Nityanand</given-names>
</name>
<xref ref-type="aff" rid="a7">7</xref>
<email>nityapkl@gmail.com</email>
</contrib>
<aff id="a1"><label>1</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00cb23x68</institution-id><institution>Department of Radiology, Kwame Nkrumah University of Science and Technology</institution></institution-wrap>, <city>Kumasi</city>, <country country="GH">Ghana</country></aff>
<aff id="a2"><label>2</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05ks08368</institution-id><institution>Department of Radiology, Komfo Anokye Teaching Hospital</institution></institution-wrap>, <city>Kumasi</city>, <country country="GH">Ghana</country></aff>
<aff id="a3"><label>3</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/00cb23x68</institution-id><institution>Department of Theoretical and Applied Biology, Kwame Nkrumah University of Science and Technology</institution></institution-wrap>, <city>Kumasi</city>, <country country="GH">Ghana</country></aff>
<aff id="a4"><label>4</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/0072zz521</institution-id><institution>Department of Environmental Health Sciences, University of Massachusetts Amherst</institution></institution-wrap>, <city>Amherst</city>, <country country="US">United States</country></aff>
<aff id="a5"><label>5</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/03qt6ba18</institution-id><institution>Department of Biology, Georgia State University</institution></institution-wrap>, <city>Atlanta</city>, <country country="US">United States</country></aff>
<aff id="a6"><label>6</label><institution-wrap><institution-id institution-id-type="ror">https://ror.org/05ks08368</institution-id><institution>Internal Medicine Directorates, Komfo Anokye Teaching Hospital</institution></institution-wrap>, <city>Kumasi</city>, <country country="GH">Ghana</country></aff>
<aff id="a7"><label>7</label><institution>Independent Statistical Consultant</institution>, <city>Chandigarh</city>, <country country="IN">India</country></aff>
</contrib-group>
<contrib-group content-type="section">
<contrib contrib-type="editor">
<name>
<surname>Yang</surname>
<given-names>Yongliang</given-names>
</name>
<role>Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Dalian University of Technology</institution>
</institution-wrap>
<city>Dalian</city>
<country>China</country>
</aff>
</contrib>
<contrib contrib-type="senior_editor">
<name>
<surname>Liu</surname>
<given-names>Caigang</given-names>
</name>
<role>Senior Editor</role>
<aff>
<institution-wrap>
<institution>Shengjing Hospital of China Medical University</institution>
</institution-wrap>
<city>Shenyang</city>
<country>China</country>
</aff>
</contrib>
</contrib-group>
<author-notes>
<fn id="n1" fn-type="equal"><label>†</label><p>Co-first authors (contributed equally)</p></fn>
<fn fn-type="coi-statement"><p>Competing interests: No competing interests declared</p></fn>
</author-notes>
<pub-date date-type="original-publication" iso-8601-date="2025-05-12">
<day>12</day>
<month>05</month>
<year>2025</year>
</pub-date>
<volume>14</volume>
<elocation-id>RP105488</elocation-id>
<history>
<date date-type="sent-for-review" iso-8601-date="2025-01-03">
<day>03</day>
<month>01</month>
<year>2025</year>
</date>
</history>
<pub-history>
<event>
<event-desc>Preprint posted</event-desc>
<date date-type="preprint" iso-8601-date="2025-01-07">
<day>07</day>
<month>01</month>
<year>2025</year>
</date>
<self-uri content-type="preprint" xlink:href="https://doi.org/10.1101/2025.01.03.25319952"/>
</event>
</pub-history>
<permissions>
<copyright-statement>© 2025, Badu-Peprah et al</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Badu-Peprah et al</copyright-holder>
<ali:free_to_read/>
<license xlink:href="https://creativecommons.org/licenses/by/4.0/">
<ali:license_ref>https://creativecommons.org/licenses/by/4.0/</ali:license_ref>
<license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link>, which permits unrestricted use and redistribution provided that the original author and source are credited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="elife-preprint-105488-v1.pdf"/>
<abstract>
<title>Abstract</title><sec>
<title>Background</title>
<p>Breast cancer associated mortality in Africa remains high due to poor survival rates, varying widely across countries. Despite medical advancements, barriers like limited access to early detection and treatment persist. This meta-analysis offers a crucial update on 5-year survival trends and influencing factors across continental Africa.</p>
</sec>
<sec>
<title>Methods</title>
<p>A systematic search of four biomedical databases and citation searching identified 79 articles from 22 African countries, analyzing 27,559 patients (97% female). A random-effects model was used to estimate the 5-year survival rate with subgroup analyses. Publication bias was assessed using Egger’s test and funnel plots.</p>
</sec>
<sec>
<title>Results</title>
<p>Pooled overall 5-year breast cancer survival in Africa averaged 48% (95% CI: 43-53%) with high statistical heterogeneity (I² = 98%). Survival was highest in Northern Africa (64%; 95% CI: 59-69%) and lowest in Western Africa (32%; 95% CI: 23-42%). Males (51%; 95% CI: 36-65%) had marginally higher survival than females (48%; 95% CI: 42-54%). Socioeconomic indices were positively associated with better outcomes. Publication bias, adjusted by the trim-and-fill method, raised survival to 62% (95% CI: 55-67%). A country-wise comparison with 2018 estimates suggests a declining survival tendency, with WHO AFRO countries reporting the poorest estimates among other WHO regions. Despite regional differences, survival trends seem to have plateaued near 48-49% level continent-wide since the early 2010s.</p>
</sec>
<sec>
<title>Conclusions</title>
<p>Our findings reveal marked regional disparities in survival rates across Africa, underscoring the urgent need for targeted healthcare interventions. Strengthening healthcare systems, ensuring universal access, and driving socioeconomic progress are vital to improving survival outcomes.</p>
</sec>
</abstract>
<kwd-group kwd-group-type="author">
<title>Keywords</title>
<kwd>breast cancer</kwd>
<kwd>Africa</kwd>
<kwd>survival</kwd>
<kwd>surveillance</kwd>
<kwd>cumulative meta-analysis</kwd>
</kwd-group>
<custom-meta-group>
<custom-meta specific-use="meta-only">
<meta-name>publishing-route</meta-name>
<meta-value>prc</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<notes notes-type="disclosures">
<title>Author Declarations</title><p>I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.</p><p>Yes</p><p>The details of the IRB/oversight body that provided approval or exemption for the research described are given below:</p><p>Not applicable.</p><p>I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.</p><p>Yes</p><p>I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).</p><p>Yes</p><p>I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.</p><p>Yes</p></notes>
</notes>
</front>
<body>
<sec id="s1">
<label>1.</label><title>Introduction</title>
<p>Breast cancer remains a significant global health concern that affects both women and men, despite the considerable progress made in early diagnostics and treatment modalities [<xref ref-type="bibr" rid="c1">1</xref>]. It is the most prevalent malignant disease among women worldwide and is the second leading cause of cancer-related mortality [<xref ref-type="bibr" rid="c2">2</xref>,<xref ref-type="bibr" rid="c3">3</xref>]. The heterogeneity and complexity in managing breast cancer is underscored by its multiple subtypes, which exhibit varying biological behaviors and clinical responses to treatment [<xref ref-type="bibr" rid="c4">4</xref>,<xref ref-type="bibr" rid="c5">5</xref>]. Notwithstanding substantial advancements in early detection and therapeutic strategies, significant survival disparities persist between high-income and low-to middle-income countries [<xref ref-type="bibr" rid="c6">6</xref>,<xref ref-type="bibr" rid="c7">7</xref>].</p>
<p>In Africa, the burden of breast cancer is particularly pronounced, with incidence and mortality rates continuing to rise. The latest estimates indicate that breast cancer leads to an estimated 186,598 new cases and 85,787 deaths annually among Africans [<xref ref-type="bibr" rid="c8">8</xref>]. Notably, regional variations in disease burden have been observed within the continent, with the highest incidence of new cases occurring in Northern and Western Africa [<xref ref-type="bibr" rid="c9">9</xref>]. Contributing factors include delayed diagnosis, inadequate healthcare infrastructure and funding, insufficient public health education initiatives, mistrust in western medicine, and significant socioeconomic barriers.</p>
<p>The most recent 5-year survival estimates for African countries were reported by a meta-analysis conducted by Ssentongo et al. [<xref ref-type="bibr" rid="c10">10</xref>]. Their study, which was limited to a search strategy till October 2018, determined that the overall 5-year survival rate in Africa was 52.9%. Subsequently, no further estimates have been collated, potentially resulting in a discrepancy between the literature and the situation on the ground. Cochrane suggests that updates should occur biennially, while Campbell reviews recommend that updates occur within a five-year cycle to facilitate the accumulation of knowledge [<xref ref-type="bibr" rid="c11">11</xref>].</p>
<p>These updates are driven by the rapid evolution of medical research and treatment methodologies, which may not align with current practices, advancements, or emerging trends observed six years ago. Additionally, the socioeconomic and healthcare landscapes in Africa are subject to continual change influenced by several factors, including policies, investments, and regional partnerships. These dynamics can significantly impact breast cancer diagnosis, treatment, and survival outcomes, highlighting the necessity for an updated analysis.</p>
<p>Hence, we believe that the integration of more recent data allows for a detailed and updated analysis of survival outcomes in Africa. The findings from our study will provide insights that can be acted upon, offering a detailed understanding of the factors influencing breast cancer survival across diverse African contexts. Such information is crucial for the development of targeted interventions, the shaping of policy decisions, and ultimately the improvement of patient outcomes across the region.</p>
</sec>
<sec id="s2">
<label>2.</label><title>Methods</title>
<p>The protocol for the present systematic review and meta-analysis was registered prospectively on PROSPERO (registration number – CRD42024595654). The Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines were followed throughout the search and study selection process to ensure transparency and completeness. Discrepancies between the registered protocol and research methodology are reported in Appendix 1.</p>
<sec id="s2a">
<label>2.1.</label><title>Data Sources and Search Strategy</title>
<p>A literature search was undertaken across multiple biomedical databases, including PubMed, Medline, Web of Science, and Scopus, to identify studies reporting 5-year survival estimates for breast cancer across African countries. The search was restricted to articles published from database inception to October 2024 to ensure the inclusion of the most recent data. We used the SPIDER framework (Sample, Phenomenon of Interest, Design, Evaluation, Research Type) to structure our search strategy as follows:</p>
<p><bold><italic>Sample (S)</italic></bold>: Patients diagnosed with breast cancer in Africa.</p>
<p><bold><italic>Phenomenon of Interest (PI):</italic></bold> 5-year survival estimates.</p>
<p><bold><italic>Design (D):</italic></bold> Observational studies, retrospective and prospective.</p>
<p><bold><italic>Evaluation (E):</italic></bold> 5-year survival rates and socio-demographic factors influencing survival.</p>
<p><bold><italic>Research Type (R):</italic></bold> Quantitative studies that report survival rates.</p>
<p>We used a combination of author keywords and Medical Subject Headings (MeSH) terms such as “breast cancer,” “five-year survival,” “Africa,” “Kaplan Meier,” and “survival.” To enhance the comprehensiveness of our search, we performed a citation search by examining the reference lists of all relevant studies and published systematic reviews and meta-analyses (<xref ref-type="supplementary-material" rid="supp2">Appendix 2</xref>). Given that literature from low-resource settings tends to be reported in non-indexed gray literature, we non-comprehensively and manually searched Google Scholar. The search comprised of the string – <italic>(“survival”) AND (“breast cancer”) AND (“name of country”)</italic> and restricted to availability of these terms in the title of the paper. This was done for all 54 countries in Africa to ensure that no data is missed from countries that were not included in previous meta-analyses. No language restrictions were applied, but studies had to include an English abstract.</p>
</sec>
<sec id="s2b">
<label>2.2.</label><title>Study Selection</title>
<p>Studies were imported into the Covidence software and duplicates were automatically removed (except Google Scholar searches). EKK, AAE, JK, and SB independently screened the titles and abstracts of all identified articles. Full-text articles were then retrieved for studies that appeared to meet the inclusion criteria based on their abstracts. Studies were included if they reported 5-year survival rates for breast cancer patients, were conducted within African countries, provided sufficient data to calculate proportions, and were published in any language. Studies that did not provide separate survival rates for breast cancer, or were editorials, commentaries, randomized control trials or reviews without original data, were excluded. Conference abstracts were included if no corresponding full-text paper was found. For full-text screening, PDFs of the non-English articles were uploaded and translated using PDFSimpli (<ext-link ext-link-type="uri" xlink:href="https://pdfsimpli.com/pdf-editor/translate-pdf/">https://pdfsimpli.com/pdf-editor/translate-pdf/</ext-link>; accessed 09th November 2024).</p>
<p>Each study was carefully evaluated against the inclusion and exclusion criteria. Any discrepancies between reviewers during the study selection process were resolved through discussion with ABP and BAG. If consensus could not be reached, a third reviewer, NJ was consulted to make the final decision. The study selection process was meticulously documented using a PRISMA flow diagram to illustrate the number of records identified, screened, and assessed for eligibility and inclusion. For Google Scholar searches, results were not considered for inclusion in PRISMA flow diagram, primarily due to the non-comprehensive nature of our search and unavailability of results for majority of countries. For countries with results, the full texts were directly screened by NJ and EKK against the inclusion criteria and the final list of included studies from other databases. No new studies were identified from Google Scholar.</p>
</sec>
<sec id="s2c">
<label>2.3.</label><title>Data Extraction</title>
<p>Data from eligible studies were independently extracted by two reviewers using a standardized data extraction Excel form. Extraction was done in pairs by EKK and SB, ABP and BAG, and AAE and JK. Extracted data included study characteristics such as authors, year of publication, country, gender, region, race, median age, sample size, overall survival (OS), and number of participants alive at the end of 5-year follow-up period (n). The country’s Human Development Index (HDI) values was classified according to its HDI ranking in 2022 [<xref ref-type="bibr" rid="c12">12</xref>]. Socio-demographic Index (SDI), a measure from the Global Burden of Disease collaboration, was categorized into quantiles to provide a comprehensive understanding of the demographic context [<xref ref-type="bibr" rid="c13">13</xref>]. We also extracted the survival rates using Webplotdigitizer v.4.5., following the method described by Tierney et al. [<xref ref-type="bibr" rid="c14">14</xref>].</p>
<p>To account for sex differences in our analysis, we categorized studies with mixed male and female participants based on a threshold criterion. Specifically, studies were classified under a specific sex group if one sex constituted at least 80% of the sample population. This cutoff was selected to ensure that the overall survival outcomes would be predominantly driven by the characteristics of the majority sex group, thereby reducing potential confounding effects from mixed-sex samples. This method, though implicitly employed by other studies [<xref ref-type="bibr" rid="c10">10</xref>,<xref ref-type="bibr" rid="c15">15</xref>], validates its use in our work. Furthermore, we believe that such a methodological approach allows for a more accurate representation of the primary variable of interest in the sex-specific survival analysis. When necessary, corresponding authors were contacted to obtain additional information or clarifications. Any discrepancies in data extraction were resolved through consultation with a third reviewer, NJ. The extracted data were then reviewed and validated by the research team to ensure accuracy and consistency.</p>
</sec>
<sec id="s2d">
<label>2.4.</label><title>Quality Assessment</title>
<p>The quality assessment of the included studies was adapted from the methodology outlined by Ssentongo et al. (<xref ref-type="supplementary-material" rid="supp3">Appendix 3</xref>) [<xref ref-type="bibr" rid="c10">10</xref>]. This method was selected for its specificity to breast cancer meta-analysis and its ability to provide numerical outcomes that can be used to assess study-level covariates. The approach evaluates studies based on three primary criteria – detailed demographic information, stratified reporting of survival, and sample size. Each criterion has a maximum score, with demographic information scoring up to 11 points, stratified reporting of survival up to 7 points, and sample size up to 6 points. The higher the number of points, the better the quality of the assessed study.</p>
</sec>
<sec id="s2e">
<label>2.5.</label><title>Data Analysis</title>
<p>The survival rates were pooled using the random effects inverse variance method, employing the “<italic>metaprop</italic>” function in the &lt;<italic>meta</italic>&gt; package of R v.4.4.0. Proportions were transformed using the logit transformation, and the 95% confidence interval (CI) was based on the Clopper-Pearson interval (exact binomial interval). To estimate heterogeneity variance, we used the Restricted Maximum Likelihood (REML) method, which is more suitable for sub-groups involving a small number of studies, as the DerSimonian method can be misleading [<xref ref-type="bibr" rid="c16">16</xref>,<xref ref-type="bibr" rid="c17">17</xref>]. Subgroup analyses were conducted based on geographic region (Northern, Eastern, Central, Western, Southern Africa), patient sex and ethnicity, Human Development Index (HDI), Social Development Index (SDI), individual countries, and year of publication.</p>
<p>Statistical heterogeneity was assessed using the I² statistic and Cochran’s Q test. Publication bias was evaluated with funnel plots and Egger’s test, with adjustments made using the fill and trim method. Additionally, a limit meta-analysis was conducted. Meta-regression analyses examined the influence of study-level covariates on survival outcomes. The &lt;<italic>metafor</italic>&gt; and &lt;<italic>orchard</italic>&gt; packages were used for the meta-regression. A cumulative meta-analysis was conducted to assess changes in survival rates in Africa over time. We compared our results to previously reported estimates for Africa and other World Health Organization (WHO) regions using one-sample Z test.</p>
</sec>
</sec>
<sec id="s3">
<label>3.</label><title>Results</title>
<p>A total of 3884 records were identified through a comprehensive search of four biomedical databases and citation searching. After a thorough screening of abstracts, titles, and full texts, 79 records were deemed eligible for inclusion (<xref rid="fig1" ref-type="fig">Figure 1</xref>) [<xref ref-type="bibr" rid="c18">18</xref>–<xref ref-type="bibr" rid="c96">96</xref>]. As some records presented data for multiple countries or demographics within a single record, we designated a reference as a “record”, while each corresponding data was termed as a “study”. Accordingly, we included 88 studies in the pooled meta-analysis. Similarly, 91 studies were analyzed for sex-specific survival outcomes. Data from 27,559 individuals was pooled in our study, with a female-to-male ratio of 26,709 to 850 (97% to 3%), respectively. The articles were sourced from 22 of the 54 countries in Africa. Study and sampling characteristics are summarized in <xref ref-type="supplementary-material" rid="supp4">Appendix 4</xref>.</p>
<fig id="fig1" position="float" orientation="portrait" fig-type="figure">
<label>Figure 1.</label>
<caption><title>PRISMA flowchart.</title>
<p>Flowchart showing the number of records identified, screened, and deemed eligible for pooled meta-analysis.</p></caption>
<graphic xlink:href="25319952v1_fig1.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig2" position="float" orientation="portrait" fig-type="figure">
<label>Figure 2.</label>
<caption><title>Sub-group meta-analysis for 5-year breast cancer survival rates across Africa.</title>
<p>The blue box represents the overall survival rate of the respective sub-groups, while the red box indicates the pooled overall survival rate. The horizontal lines traversing each box depict the corresponding confidence intervals. P<sub>hetero</sub> represents the P value for heterogeneity test while P<sub>subgroup</sub> indicates the P value for the test for subgroup analysis. I<sup>2</sup> represents the statistical heterogeneity (%) in the analysis. N/A – not applicable due to single study meta-analysis.</p></caption>
<graphic xlink:href="25319952v1_fig2.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<fig id="fig3" position="float" orientation="portrait" fig-type="figure">
<label>Figure 3.</label>
<caption><title>Cumulative meta-analysis for 5-year survival rates in Africa, adding studies in chronological order.</title>
<p>The blue box represents the overall survival rate of the respective study, while the horizontal lines traversing each box depict the corresponding confidence intervals. Tau, Tau<sup>2</sup>, and I<sup>2</sup> represent the different measures of statistical heterogeneity in the pooled estimate.</p></caption>
<graphic xlink:href="25319952v1_fig3.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<sec id="s3a">
<label>3.1.</label><title>Meta-analysis</title>
<p>The overall pooled survival rate was 48% (95% CI: 43-53%), with high heterogeneity (I² = 97.9%), indicating substantial variability among the included studies. Sub-group-wise, a marginal discrepancy in survival rates was observed between the sexes, with females exhibiting a slightly lower survival rate (48%) compared to males (51%), though this difference was not statistically significant. However, a significant ethnic disparity was observed, with African non-black patients exhibiting a higher survival rate (62%) compared to African black patients (38%). Survival rates were also found to be significantly correlated with socioeconomic development. Regions exhibiting higher human development index (HDI) levels demonstrated superior outcomes, with high HDI regions exhibiting a 60% survival rate, medium HDI regions a 42% survival rate, and low HDI regions a 37% survival rate.</p>
<p>A similar pattern was observed with the Socio-demographic Index (SDI), where high-middle SDI regions exhibited the highest survival rate (62%) and low SDI regions exhibited the lowest (34%). Furthermore, it was observed that studies published prior to 2019 indicated a higher survival rate (49%) than those conducted from 2019 onwards (44%). Although the impact of the COVID-19 pandemic might be considered a contributing factor in this decline, we would urge caution in this interpretation. The reported studies were conducted retrospectively, and the year of publication may not be a reliable measure of the effect in question. This observed decline has been explored and addressed in greater detail later in the paper.</p>
<p>Furthermore, considerable variability was observed across African regions, with Northern Africa having the highest survival rate (64%) and Western Africa having the lowest (32%). Country-specific analyses indicate that Mauritius (73%) and Namibia (70%) recorded the highest survival rates, whereas the Gambia (11%) had the lowest rates.</p>
<p>We next conducted a cumulative chronological meta-analysis to examine the evolution and trajectory of 5-year survival rates. The analysis, which commenced with Tabbane et al., (1977) [<xref ref-type="bibr" rid="c68">68</xref>] and concluded with Gnangnon et al., (2024) [<xref ref-type="bibr" rid="c83">83</xref>], revealed interesting trends. The observed survival rates ranged from 15% to 50% between 1977 and 2024. The P values, which were calculated by comparing the observed effect with a previously reported null effect of 47%, exhibited considerable variation. Among the included studies, only three demonstrated statistically significant results (P &lt; 0.05) from this null effect. As the number of studies increased, the overall survival rate rose and the confidence intervals narrowed, reflecting enhanced precision in the cumulative estimate. However, since the early 2010s, the overall survival rate has stabilized around 48-50%, with no discernible or predictable trend in the future.</p>
</sec>
<sec id="s3b">
<label>3.2.</label><title>Meta-regression</title>
<p>Meta-regression analyses were performed to evaluate the influence of different factors on 5-year survival rates. Among the continuous factors, mean years of schooling (MYS) and quality score (QS) of the included studies were both found to have significant influences (P = 0.001 and 0.023, respectively). MYS and QS accounted for 10.85% and 4.80% of the heterogeneity in survival, respectively. Each additional year of mean schooling was associated with a 2.41% (95% CI: 0.98-3.84%) increase in 5-year survival. Similarly, each 1-point increase in quality score was associated with a 1.39% (95% CI: 0.19-2.59%) increase in survival (<xref rid="fig4" ref-type="fig">Figure 4</xref>).</p>
<fig id="fig4" position="float" orientation="portrait" fig-type="figure">
<label>Figure 4.</label>
<caption><title>Bubble plots for the relationship between mean years of schooling (MYS) and quality score (QS) of the included studies with the 5-year survival rate of breast cancer patients.</title>
<p>Each point represents a study, with the size of the points indicating the precision (1/standard error) of the data. The solid black line represents the regression line, the dashed lines indicate the 95% confidence intervals, and the dotted lines show the prediction intervals.</p></caption>
<graphic xlink:href="25319952v1_fig4.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>Additional analyses for categorical predictors revealed significant associations for survival rates with country, patient ethnicity, African continental regions, HDI quartiles, and SDI quintiles, indicating that survival rates are significantly influenced by these factors. However, no significant associations were found for patient sex and year of publication (<xref rid="fig5" ref-type="fig">Figure 5</xref>).</p>
<fig id="fig5" position="float" orientation="portrait" fig-type="figure">
<label>Figure 5.</label>
<caption><title>Orchard plots for the meta-regression analyses of the 5-year survival rate and categorical predictors.</title>
<p>The plots show the pooled survival rate (trunk), 95% confidence intervals (branches), and prediction intervals (twigs). Bubble sizes indicate precision (1/standard error) of each study, with larger points representing higher precision.</p></caption>
<graphic xlink:href="25319952v1_fig5.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
</sec>
<sec id="s3c">
<label>3.3.</label><title>Publication Bias and Small Study Effects</title>
<p>We used the Egger’s test to assess funnel plot asymmetry. The test result indicated significant asymmetry and was considered suggestive of potential publication bias (t =-3.15, P = 0.002. The bias estimate was-4.007 with a standard error (SE) of 1.271. Next, the trim-and-fill test was performed which included 114 studies, with 26 hypothetical studies added to adjust for bias (<xref rid="fig6" ref-type="fig">Figure 6</xref>). The adjusted 5-year survival rate using the random effects model was 62% (95% CI: 55-67%), with a prediction interval ranging from 10-96%. This adjustment indicates that the true effect size is likely to be within this broader range, accounting for potential missing studies.</p>
<fig id="fig6" position="float" orientation="portrait" fig-type="figure">
<label>Figure 6.</label>
<caption><title>Funnel plots for assessing publication bias in studies reporting breast cancer survival rates.</title>
<p>Standard funnel plot for 88 studies (panel A); contour-enhanced funnel plot for 88 studies (panel B); Trim-and-fill funnel plot with 26 hypothetical studies (white dots) added to 88 studies (gray dots; panel C); and Limit meta-analysis funnel plot showing increasing bias with standard error. Gray diamond shows the adjusted average effect when standard error is zero.</p></caption>
<graphic xlink:href="25319952v1_fig6.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>The analysis still quantified substantial heterogeneity among the included studies, with a tau-square (τ<sup>2</sup>) value of 1.837 (95% CI: 1.446-2.509). The I<sup>2</sup> statistic was observed to be extremely high at 98.4% (95% CI: 98.3-98.5%), indicating that nearly all the variability in effect estimates is due to heterogeneity rather than random chance. The limit meta-analysis, on the other hand, provided a 5-year survival estimate of 52% (95% CI: 45-59%).</p>
<p>Heterogeneity statistics indicated a τ<sup>2</sup> value of 0.9287, with an I² of 97.9% (95% CI: 97.7-98.1%), reflecting substantial heterogeneity among the studies. Additionally, the test for small-study effects demonstrated Q-Q’ of 430.25 (P &lt; 0.0001), suggesting the presence of small-study effects. The residual heterogeneity test produced Q’ = 3719.79 (P &lt; 0.0001), indicating significant residual heterogeneity beyond small-study effects.</p>
</sec>
<sec id="s3d">
<label>3.4.</label><title>Comparison with 2018 African Estimates</title>
<p>A previous meta-analysis, which included literature up to October 2018, identified 54 eligible records from 14 countries [<xref ref-type="bibr" rid="c10">10</xref>]. The authors reported a pooled overall 5-year survival rate of 53% (95% CI: 46-60%), while our own findings indicated an estimate of 48% (95% CI: 43-53%). We conducted a one-sample Z-test for proportions to compare the two estimates and found no statistical significance (P = 0.071). Nonetheless, given that our estimates indicated a lower survival rate than previously reported, we explored the cause for this observation.</p>
<p>At first, we postulated that our larger and more diverse data set, comprising 22 countries, could have yielded a more precise estimate. To explore this, we subset our data into two groups, one part with data from same 14 countries as reported from 2018 meta-analysis and the other part with data from 8 new countries (<xref rid="fig7" ref-type="fig">Figure 7</xref>). The forest plot demonstrated that the estimate derived from the former group remained inferior to the estimates reported by the 2018 study (47% vs 53%).</p>
<fig id="fig7" position="float" orientation="portrait" fig-type="figure">
<label>Figure 7.</label>
<caption><title>Comparison of our current 5-year survival estimates with the previous 2018 estimates.</title>
<p>A territorial map of continental Africa is shown (on the left) with 5-year survival estimates and 95% confidence interval from 2018 and 2024. The survival estimates have been rounded off to the nearest whole number. Two forest plots are shown (on the right) that were used to estimate the effect of addition of eight new countries in our 2024 estimates and the effect of missed/excluded references in the 2018 estimates.</p></caption>
<graphic xlink:href="25319952v1_fig7.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>Subsequently, we cross-referenced the meta-analyzed studies from the previous work and those from the present study. We observed that the authors had not included 10 studies that were published before 2018 and met their inclusion criteria, potentially attributable to the limited number of databases they searched (Medline, Embase, and Cochrane Library). These studies were from Uganda, Gambia, Ghana, Ethiopia, Nigeria, Cameroon, Sudan, and Zimbabwe. Inclusion of these 10 studies yielded an estimated 5-year survival rate of 49% (95% CI: 43-56%; <xref rid="fig7" ref-type="fig">Figure 7</xref>), which is in close alignment with our pooled overall survival rate of 48%.</p>
<p>This decrease observed in 2018 estimates was expected since the studies not included were primarily from low and low-middle SDI countries. In our view, these findings have two broader public health ramifications. First, although not significantly different from our estimates, the previously reported survival estimates appear to be inflated due to incomplete catch from the investigated biomedical databases, highlighting the need for a comprehensive search strategy. Second, as observed with our cumulative meta-analysis, the 5-year survival rate has somewhat stagnated in Africa. Apart from Ghana, all other countries either observed a modest decrease or no change in 5-year survival estimates (<xref rid="fig7" ref-type="fig">Figure 7</xref>). Burkina Faso and Uganda experienced the largest declines, although the one-sample z-test for proportions was not significant (P = 0.268 and 0.195, respectively).</p>
</sec>
<sec id="s3e">
<label>3.5.</label><title>Comparison with Global Estimates among Female Patients</title>
<p>We also conducted a generic Google Scholar and PubMed search to look for pooled 5- year survival rates for breast cancer patients. The search was specifically designed to retrieve systematic reviews and meta-analyses published in the last decade that included data from multiple countries and had pooled the results based on either regional grouping, WHO regions, or at the continent level. Consequently, three such studies were identified for comparison [<xref ref-type="bibr" rid="c97">97</xref>–<xref ref-type="bibr" rid="c99">99</xref>]. Given that these studies reported survival rates exclusively for female patients, they were compared with our estimates derived from the female subset only (<xref rid="fig8" ref-type="fig">Figure 8</xref>).</p>
<fig id="fig8" position="float" orientation="portrait" fig-type="figure">
<label>Figure 8.</label>
<caption><title>Comparison of our current 5-year survival estimates with the previously reported global estimates.</title>
<p>Forest plot showing the pooled meta-analyzed overall 5-year survival rate with 95% confidence interval for female patients with breast cancer across different regions. WHO – World Health Organization; PAHO – Pan American Health Organization; WPRO – Western Pacific Region; SEARO – South-East Asia Region; EURO – European Region; EMRO – Eastern Mediterranean Region; AFRO – African Region; ASEAN – Association of Southeast Asian Nations.</p></caption>
<graphic xlink:href="25319952v1_fig8.tif" mime-subtype="tiff" mimetype="image"/>
</fig>
<p>A comparative analysis of five-year survival rates for female patients across different regions revealed significant differences between our 2024 estimates and previously reported estimates from all regions (one-sample Z test P &lt; 0.001), except for the WHO SEARO region (one-sample Z test P = 0.469). In 2017, the WHO WPRO and PAHO regions recorded the highest global survival rates of 76% and 75%, respectively. Similarly, the WHO EURO and WHO EMRO regions reported high survival rates of 74% and 71%, respectively.</p>
<p>Although the survival rate in the WHO SEARO region was slightly higher than our 2024 estimates, there is clearly room for improvement in both regions. Notably, the estimates from the WHO AFRO region, based on just four studies, reported a much lower survival rate of 28% in 2017. Upon subsetting and analyzing the results for female patients from WHO AFRO countries (48 studies; 17 countries), we observed a 5-year survival rate of 38% (95% CI: 32-44%). This indicates a considerable improvement in the WHO AFRO region’s survival rate by 2024. Despite this progress, the survival rate remains substantially lower than in other WHO regions.</p>
</sec>
</sec>
<sec id="s4">
<label>4.</label><title>Discussion</title>
<p>Our meta-analysis of 5-year survival rates for breast cancer patients in Africa offers comprehensive insights into the current state of clinical outcomes across the continent. We underscore the considerable disparities in survival rates across different regions and socio-economic contexts. The overall survival rate of 48% in Africa is markedly lower than those reported in high-income countries, where survival rates frequently exceed 70-80% [<xref ref-type="bibr" rid="c97">97</xref>–<xref ref-type="bibr" rid="c99">99</xref>].</p>
<p>The sex-stratified analysis indicated no differences in survival rates between male and female patients, suggesting that both genders encounter considerable challenges in the context of early diagnostics and timely and effective treatment. In their study, Gómez-Raposo et al., found that when age is accounted, breast cancer survival rates are similar for both males and females [<xref ref-type="bibr" rid="c100">100</xref>]. Others have also reported similar findings when the cohorts were age-, region-, stage-, and/or propensity-matched [<xref ref-type="bibr" rid="c101">101</xref>–<xref ref-type="bibr" rid="c104">104</xref>]. Nonetheless, the marginally higher survival rate observed in males is interesting, as literature seems to suggest a worse prognosis for male breast cancer patients. The lower survival rate observed in males has been suggested due to males having a greater likelihood of being diagnosed at an older age, a higher prevalence of advanced disease stages, and a tendency to adhere less strictly to treatment regimens [<xref ref-type="bibr" rid="c105">105</xref>]. Furthermore, the issue is compounded by a lack of awareness and the absence of targeted screening programs for male patients.</p>
<p>In the context of our study, data were available for male patients only from nine countries in Africa. The rarity of male breast cancer surveillance and reporting may have resulted in the inclusion of smaller, non-representative cohorts, thereby influencing the observed outcomes. Furthermore, our methodological approach of categorizing studies based on a threshold criterion (≥80% of one sex) may also contribute to this observation. Finally, it may also be due to the absence of triple-negative cases in the male cohort, suggesting that certain aggressive subtypes are less common among African men [<xref ref-type="bibr" rid="c106">106</xref>]. This absence of aggressive difficult-to-manage phenotypes could influence and contribute to the observed higher survival rates.</p>
<p>Furthermore, African black women are more likely to be diagnosed with aggressive subtypes of breast cancer, such as triple-negative breast cancer (TNBC) [<xref ref-type="bibr" rid="c105">105</xref>,<xref ref-type="bibr" rid="c107">107</xref>]. TNBC is characterized by the absence of estrogen, progesterone, and HER2 receptors, which renders it more challenging to treat and is associated with a poorer prognosis [<xref ref-type="bibr" rid="c108">108</xref>–<xref ref-type="bibr" rid="c109">109</xref>]. The <italic>ANKLE1</italic> gene, which confers protection against TNBC, was found to be less prevalent in African American women compared to white women of European descent [<xref ref-type="bibr" rid="c110">110</xref>]. Moreover, African American women with a mutation in the Duffy (<italic>DARC</italic>) gene, which is involved in the inflammatory response, have an elevated risk of developing TNBC [<xref ref-type="bibr" rid="c110">110</xref>].</p>
<p>Northern Africa, with its relatively high survival rates, benefits from a more robust healthcare infrastructure, more efficacious screening programs, and greater public awareness about breast cancer. It is frequently the case that countries in this region are ranked high on HDI and SDI evaluations [<xref ref-type="bibr" rid="c12">12</xref>–<xref ref-type="bibr" rid="c13">13</xref>]. Conversely, the lowest survival rates are observed in Western Africa, which highlights the necessity for significant investments in healthcare services and resource allocation. A country-specific analysis revealed significant contrasts, with Mauritius recording the highest survival rate and Gambia having the lowest. These discrepancies may be attributable to discrepancies in healthcare systems, the availability of cancer treatment facilities, and national and international health partnerships and policies.</p>
<p>For example, in Mauritius, healthcare is regarded as a fundamental human right, with free public health services for primary care being made available. Every household is situated within three miles of a primary care provider, thereby ensuring accessible medical care for all. Active investments are being made by the Ministry of Health and Wellness to construct a national cancer hospital, while upgrading facilities at regional hospitals to ensure that cancer treatment is provided free of charge to all citizens [<xref ref-type="bibr" rid="c111">111</xref>]. In contrast, the availability of facilities for breast cancer screening, diagnosis, and treatment in Gambia is limited. Many of the diagnostic and care centers are located at distances ranging from 10 to 45 kilometers from patients’ residences. Consequently, nearly half of the Gambian population lacks access to pathologic diagnosis and surgical management of breast cancer within these distance thresholds [<xref ref-type="bibr" rid="c112">112</xref>]. In other countries with high overall breast cancer survival rates, such as Seychelles and Namibia, which have higher HDI values, the density of healthcare professionals (HCPs) per 1,000 population exceeds the United Nations Sustainable Development Goals (SDG) density target of 4.45 HCPs per 1,000 population. Furthermore, these countries maintain healthcare quality ratings above 80% [<xref ref-type="bibr" rid="c113">113</xref>].</p>
<p>A comparison of the 2024 estimates with the adjusted 2018 estimate and the findings from our cumulative meta-analysis indicates a stagnation of survival rates around 48-49% over time. This may be attributed to several factors. The healthcare infrastructure across many African countries remains underdeveloped, with the availability of essential diagnostic tools and advanced treatment options remaining constrained, particularly in rural and low-resource settings [<xref ref-type="bibr" rid="c114">114</xref>]. This inadequacy results in delayed diagnoses and suboptimal treatment outcomes. Socioeconomic and cultural mistrust in Western medicine, in conjunction with pervasive poverty and economic disparities, impede the capacity of patients to access essential healthcare services at a reasonable cost [<xref ref-type="bibr" rid="c115">115</xref>–<xref ref-type="bibr" rid="c116">116</xref>]. Traditional beliefs and stigma associated with cancer can act as a deterrent for individuals seeking medical care [<xref ref-type="bibr" rid="c117">117</xref>–<xref ref-type="bibr" rid="c118">118</xref>]. Despite the importance of efforts to raise awareness and educate the population about the significance of early detection and treatment, initiatives have thus far proven inadequate in terms of both scope and impact.</p>
<p>Systemic issues, including political instability and corruption, serve to further exacerbate these challenges, impeding the implementation of cancer care programs [<xref ref-type="bibr" rid="c119">119</xref>]. Ultimately, inadequate financial resources have an adverse ripple effect throughout the healthcare system, from the unavailability of essential medications to the lack of sufficient training for HCPs, perpetuating a vicious cycle of inadequate care and poor patient outcomes. Our observations also highlight that sustained improvements in particular regions or countries are insufficient to significantly alter the overall continental survival rate. The considerable heterogeneity observed in the studies highlights the uneven distribution of healthcare resources and the variable quality of care across different countries and regions.</p>
<p>Another notable finding was the positive correlation between mean years of schooling (MYS) and breast cancer survival rates. Education plays a crucial role in enhancing health outcomes by fostering health literacy, which provides for greater awareness of breast cancer symptoms, the significance of early detection, and adherence to treatment regimens. Higher levels of educational attainment afford patients the ability to navigate the healthcare system with greater confidence and to make more informed decisions regarding their care. Furthermore, the analysis underscores the influence of study quality on the reported survival rates, indicating that higher-quality studies are associated with more favorable survival outcomes. This highlights the necessity of rigorous study design and adherence to methodological standards to produce reliable and accurate data. The quality of the studies included in the meta-analysis is reflective of the variability in healthcare infrastructure, research funding, and expertise across different regions.</p>
<p>It is hence necessary to improve the caliber of research conducted in resource-limited settings to generate evidence-based unbiased data and subsequently inform policy and practice. The observed heterogeneity in survival rates is significantly influenced by region, country, race, SDI, and HDI. This indicates that geographical and socio-economic factors exert a more pronounced influence on breast cancer outcomes in Africa than temporal trends or gender or ethnicity. The evidence of significant publication bias, as indicated by Egger’s test, suggests that the reported survival rates may be overestimated due to the under-reporting of smaller studies with less favorable outcomes.</p>
<sec id="s4a">
<label>4.1.</label><title>Limitations</title>
<p>While we followed a comprehensive protocol, there are several methodological limitations that warrant consideration. The substantial heterogeneity among the included studies indicates significant variability in survival rates, likely due to differences in study design, population characteristics, and healthcare systems, complicating the generalization of results across the continent. The presence of publication bias suggests that smaller studies might be under-represented, potentially skewing the overall survival rate estimate despite adjustments using the trim and fill method. Additionally, the analysis included studies from only 22 out of 54 African countries, limiting the representativeness of the findings and potentially overlooking variations in survival rates in countries with no available data.</p>
<p>The reliance on published studies means that the quality and accuracy of the data are contingent on the methodologies and reporting standards of the original research, introducing inconsistencies. For instance, our approach for classification of studies based on patient sex does not fully account for the nuanced effects of sex on breast cancer outcomes and could lead to an over-estimation or under-estimation of survival rates for each sex. Additionally, while this threshold ensures the majority sex group’s characteristics predominantly drive the outcomes, it highlights the necessity for further research to comprehensively disaggregate, record, and report data by sex. Another crucial disadvantage of reporting inconsistencies is that tumor characteristics (staging, TNM classification, histological classification, localization, primary tumor/metastasis) and clinically relevant parameters (patient age, treatment modality, follow-up duration, quality of life outcomes) cannot be compared and pooled together.</p>
<p>Such limitations have been reported by previous global meta-analytical studies as well where authors reported that data from low-and middle-income countries such as those in Africa and Asia had &gt;50% of patients with unknown breast cancer stages to report [<xref ref-type="bibr" rid="c6">6</xref>]. Furthermore, assessment of tumor staging should be done using both clinical and radiological methods. However, a meta-analysis for Sub-Saharan African countries noted that &lt; 25% of the studies reported the staging methods used with a few studies relying only on clinical assessment for staging [<xref ref-type="bibr" rid="c120">120</xref>]. Finally, socio-economic factors such as income and access to healthcare, which significantly impact patient outcomes, were not fully accounted for in the analysis. Addressing these limitations in future studies will enhance the accuracy and reliability of the findings, contributing to better-informed healthcare policies and interventions.</p>
</sec>
<sec id="s4b">
<label>4.2.</label><title>Recommendations based on current estimates</title>
<p>We reiterate the longstanding and urgent necessity of implementing targeted healthcare policies to address the considerable regional disparities that are prevalent among African countries. The observed correlation between higher survival rates and countries with a high HDI, MYS, and SDI underscores the pivotal role of robust healthcare infrastructure, education, and socio-economic development in enhancing cancer care. It is incumbent upon policymakers to prioritize the allocation of resources to regions with the lowest survival rates, such as Western Africa, and to invest in the development of healthcare facilities, diagnostic tools, and treatment centers. Furthermore, it is crucial to enhance the training of HCPs in oncology, molecular diagnostics, and palliative care. Implementing culturally sensitive public health campaigns, adopting universal healthcare, and expanding insurance coverage to include cancer treatment are essential steps.</p>
<p>The considerable heterogeneity and publication bias identified in our meta-analysis underscores the need for more comprehensive and high-quality record keeping and research, including the establishment of national cancer registries. International collaboration and partnerships with global health organizations can facilitate the transfer of knowledge and the allocation of funding for improvements in cancer care. There is a need to develop and implement an Africa-wide public health framework for the development of targeted strategies that address the specific needs and challenges of different regions and populations in Africa.</p>
</sec>
</sec>
<sec id="s5">
<label>5.</label><title>Conclusions</title>
<p>Our findings highlight the significant regional disparities in breast cancer survival rates across the African continent, reinforcing the urgent and sustained need for targeted health interventions. The substantial heterogeneity among studies reflects the variability in the quality of and access to health care across countries. The higher survival rates in countries with high HDI and SDI values underscore the importance of robust health systems and socioeconomic development in improving survival. Gender differences in survival were found not to be a covariate, highlighting the importance of controlling for other clinical and socio-demographic factors. These findings provide a roadmap for developing effective cancer screening programs and health policies, including implementation of uniform reporting standards and establishment of national cancer registries, to improve breast cancer surveillance, monitoring, and survival rates across the continent.</p>
</sec>
<sec id="s6">
<label>6.</label><title>Declarations</title>
<list list-type="alpha-lower">
<list-item><p><bold>Conflicts of interest</bold> – None to declare.</p></list-item>
<list-item><p><bold>Funding</bold> – None to declare.</p></list-item>
<list-item><p><bold>Ethical approval</bold> – Not applicable.</p></list-item>
<list-item><p><bold>Data Availability</bold> – All data generated is presented in the manuscript and appendices. Clarifications on methodology and requests for the R code can be directed to the corresponding authors.</p></list-item>
<list-item><p><bold>Informed Consent</bold> – Not applicable.</p></list-item>
<list-item><p><bold>Acknowledgements</bold> – None to declare.</p></list-item>
<list-item><p><bold>Author contributions</bold> – ABP and NJ conceptualized the present study. Data curation, collection, and screening was done by ABP, EKK, AGB, JK, AAE, BS, IN, and BOO with inputs and validation from NJ. Methodology, investigations, visualizations, and formal analysis were done by EKK and NJ. Software and code were maintained by EKK and NJ. Project administration and supervision was done by ABP and NJ. Data validation was done by EKK and NJ. The original draft was prepared by EKK, JK, ABP, and NJ while all authors were involved in revising the manuscript. All authors have read the manuscript and agreed on its contents for publication.</p></list-item>
</list>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="d1e1177">
<title>Data availability</title>
<p>All data generated is presented in the manuscript and appendices. Clarifications on methodology and requests for the R code can be directed to the corresponding authors.</p>
</sec>
<sec id="s9" sec-type="supplementary-material">
<title>Additional files</title>
<supplementary-material id="supp1">
<label>Appendix 1.</label>
<media xlink:href="25319952v1_supp1.pdf"/>
</supplementary-material>
<supplementary-material id="supp2">
<label>Appendix 2.</label>
<media xlink:href="25319952v1_supp2.pdf"/>
</supplementary-material>
<supplementary-material id="supp3">
<label>Appendix 3.</label>
<media xlink:href="25319952v1_supp3.pdf"/>
</supplementary-material>
<supplementary-material id="supp4">
<label>Supplementary file 1.</label>
<media xlink:href="25319952v1_supp4.xlsx"/>
</supplementary-material>
</sec>
<ref-list>
<title>References</title>
<ref id="c1"><label>1.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wilkinson</surname> <given-names>L</given-names></string-name>, <string-name><surname>Gathani</surname> <given-names>T</given-names></string-name></person-group>. <article-title>Understanding breast cancer as a global health concern</article-title>. <source>Br J Radiol</source>. <year>2022</year> Feb 1;<volume>95</volume>(<issue>1130</issue>):<elocation-id>20211033</elocation-id>. doi: <pub-id pub-id-type="doi">10.1259/bjr.20211033</pub-id>. Epub 2021 Dec 14. PMID: <pub-id pub-id-type="pmid">34905391</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC8822551</pub-id>.</mixed-citation></ref>
<ref id="c2"><label>2.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Coles</surname> <given-names>CE</given-names></string-name>, <string-name><surname>Earl</surname> <given-names>H</given-names></string-name>, <string-name><surname>Anderson</surname> <given-names>BO</given-names></string-name>, <string-name><surname>Barrios</surname> <given-names>CH</given-names></string-name>, <string-name><surname>Bienz</surname> <given-names>M</given-names></string-name>, <string-name><surname>Bliss</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Cameron</surname> <given-names>DA</given-names></string-name>, <string-name><surname>Cardoso</surname> <given-names>F</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>The Lancet Breast Cancer Commission</article-title>. <source>Lancet</source>. <year>2024</year> May 11;<volume>403</volume>(<issue>10439</issue>):<fpage>1895</fpage>–<lpage>1950</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S0140-6736(24)00747-5</pub-id>. Epub 2024 Apr 15. PMID: <pub-id pub-id-type="pmid">38636533</pub-id>.</mixed-citation></ref>
<ref id="c3"><label>3.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sha</surname> <given-names>R</given-names></string-name>, <string-name><surname>Kong</surname> <given-names>XM</given-names></string-name>, <string-name><surname>Li</surname> <given-names>XY</given-names></string-name>, <string-name><surname>Wang</surname> <given-names>YB</given-names></string-name></person-group>. <article-title>Global burden of breast cancer and attributable risk factors in 204 countries and territories, from 1990 to 2021: results from the Global Burden of Disease Study 2021</article-title>. <source>Biomark Res</source>. <year>2024</year> Aug 26;<volume>12</volume>(<issue>1</issue>):<fpage>87</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s40364-024-00631-8</pub-id>. PMID: <pub-id pub-id-type="pmid">39183342</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC11346191</pub-id>.</mixed-citation></ref>
<ref id="c4"><label>4.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Testa</surname>, <given-names>U</given-names></string-name>, <string-name><surname>Castelli</surname>, <given-names>G</given-names></string-name>, <string-name><surname>Pelosi</surname>, <given-names>E</given-names></string-name></person-group>. <article-title>Breast Cancer: A Molecularly Heterogenous Disease Needing Subtype-Specific Treatments</article-title>. <source>Med Sci (Basel)</source>. <year>2020</year> Mar 23;<volume>8</volume>(<issue>1</issue>):<fpage>18</fpage>. doi: <pub-id pub-id-type="doi">10.3390/medsci8010018</pub-id>. PMID: <pub-id pub-id-type="pmid">32210163</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC7151639</pub-id>.</mixed-citation></ref>
<ref id="c5"><label>5.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Turner</surname> <given-names>KM</given-names></string-name>, <string-name><surname>Yeo</surname> <given-names>SK</given-names></string-name>, <string-name><surname>Holm</surname> <given-names>TM</given-names></string-name>, <string-name><surname>Shaughnessy</surname> <given-names>E</given-names></string-name>, <string-name><surname>Guan</surname> <given-names>JL</given-names></string-name></person-group>. <article-title>Heterogeneity within molecular subtypes of breast cancer</article-title>. <source>Am J Physiol Cell Physiol</source>. <year>2021</year> Aug 1;<volume>321</volume>(<issue>2</issue>):<fpage>C343</fpage>-<lpage>C354</lpage>. doi: <pub-id pub-id-type="doi">10.1152/ajpcell.00109.2021</pub-id>. Epub 2021 Jun 30. PMID: <pub-id pub-id-type="pmid">34191627</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC8424677</pub-id>.</mixed-citation></ref>
<ref id="c6"><label>6.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>Benitez</given-names> <surname>Fuentes JD</surname></string-name>, <string-name><surname>Morgan</surname> <given-names>E</given-names></string-name>, <string-name><surname>de Luna Aguilar</surname> <given-names>A</given-names></string-name>, <string-name><surname>Mafra</surname> <given-names>A</given-names></string-name>, <string-name><surname>Shah</surname> <given-names>R</given-names></string-name>, <string-name><surname>Giusti</surname> <given-names>F</given-names></string-name>, <string-name><surname>Vignat</surname> <given-names>J</given-names></string-name>, <string-name><surname>Znaor</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Global Stage Distribution of Breast Cancer at Diagnosis: A Systematic Review and Meta-Analysis</article-title>. <source>JAMA Oncol</source>. <year>2024</year> Jan 1;<volume>10</volume>(<issue>1</issue>):<fpage>71</fpage>–<lpage>78</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jamaoncol.2023.4837</pub-id>. PMID: <pub-id pub-id-type="pmid">37943547</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC10636649</pub-id>.</mixed-citation></ref>
<ref id="c7"><label>7.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Birnbaum</surname> <given-names>JK</given-names></string-name>, <string-name><surname>Duggan</surname> <given-names>C</given-names></string-name>, <string-name><surname>Anderson</surname> <given-names>BO</given-names></string-name>, <string-name><surname>Etzioni</surname> <given-names>R</given-names></string-name></person-group>. <article-title>Early detection and treatment strategies for breast cancer in low-income and upper middle-income countries: a modelling study</article-title>. <source>Lancet Glob Health</source>. <year>2018</year> Aug;<volume>6</volume>(<issue>8</issue>):<fpage>e885</fpage>–<lpage>e893</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S2214-109X(18)30257-2</pub-id>. PMID: <pub-id pub-id-type="pmid">30012269</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC6214657</pub-id>.</mixed-citation></ref>
<ref id="c8"><label>8.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Anyigba</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Awandare</surname> <given-names>GA</given-names></string-name>, <string-name><surname>Paemka</surname> <given-names>L</given-names></string-name></person-group>. <article-title>Breast cancer in sub-Saharan Africa: The current state and uncertain future</article-title>. <source>Exp Biol Med (Maywood)</source>. <year>2021</year> Jun;<volume>246</volume>(<issue>12</issue>):<fpage>1377</fpage>–<lpage>1387</lpage>. doi: <pub-id pub-id-type="doi">10.1177/15353702211006047</pub-id>. Epub 2021 Apr 29. PMID: <pub-id pub-id-type="pmid">33926257</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC8243219</pub-id>.</mixed-citation></ref>
<ref id="c9"><label>9.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Arnold</surname> <given-names>M</given-names></string-name>, <string-name><surname>Morgan</surname> <given-names>E</given-names></string-name>, <string-name><surname>Rumgay</surname> <given-names>H</given-names></string-name>, <string-name><surname>Mafra</surname> <given-names>A</given-names></string-name>, <string-name><surname>Singh</surname> <given-names>D</given-names></string-name>, <string-name><surname>Laversanne</surname> <given-names>M</given-names></string-name>, <string-name><surname>Vignat</surname> <given-names>J</given-names></string-name>, <string-name><surname>Gralow</surname> <given-names>JR</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Current and future burden of breast cancer: Global statistics for 2020 and 2040</article-title>. <source>Breast</source>. <year>2022</year> Dec;<volume>66</volume>:<fpage>15</fpage>–<lpage>23</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.breast.2022.08.010</pub-id>. Epub 2022 Sep 2. PMID: <pub-id pub-id-type="pmid">36084384</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC9465273</pub-id>.</mixed-citation></ref>
<ref id="c10"><label>10.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ssentongo</surname> <given-names>P</given-names></string-name>, <string-name><surname>Lewcun</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Candela</surname> <given-names>X</given-names></string-name>, <string-name><surname>Ssentongo</surname> <given-names>AE</given-names></string-name>, <string-name><surname>Kwon</surname> <given-names>EG</given-names></string-name>, <string-name><surname>Ba</surname> <given-names>DM</given-names></string-name>, <string-name><surname>Oh</surname> <given-names>JS</given-names></string-name>, <string-name><surname>Amponsah-Manu</surname> <given-names>F</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Regional, racial, gender, and tumor biology disparities in breast cancer survival rates in Africa: A systematic review and meta-analysis</article-title>. <source>PLoS One</source>. <year>2019</year> Nov 21;<volume>14</volume>(<issue>11</issue>):<fpage>e0225039</fpage>. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0225039</pub-id>. PMID: <pub-id pub-id-type="pmid">31751359</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC6872165</pub-id>.</mixed-citation></ref>
<ref id="c11"><label>11.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lakens</surname> <given-names>D</given-names></string-name>, <string-name><surname>Hilgard</surname> <given-names>J</given-names></string-name>, <string-name><surname>Staaks</surname> <given-names>J</given-names></string-name></person-group>. <article-title>On the reproducibility of meta-analyses: six practical recommendations</article-title>. <source>BMC Psychol</source>. <year>2016</year> <month>May</month> 31;<volume>4</volume>(<issue>1</issue>):<fpage>24</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s40359-016-0126-3</pub-id>. PMID: <pub-id pub-id-type="pmid">27241618</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC4886411</pub-id>.</mixed-citation></ref>
<ref id="c12"><label>12.</label><mixed-citation publication-type="report"><person-group person-group-type="author"><collab>United Nations Development Programme (UNDP)</collab></person-group>. Human Development Reports: Human Development Index (HDI). <year>2024</year> [online]. Available from <ext-link ext-link-type="uri" xlink:href="https://hdr.undp.org/data-center/human-development-index#/indicies/HDI">https://hdr.undp.org/data-center/human-development-index#/indicies/HDI</ext-link> (accessed 1st November 2024).</mixed-citation></ref>
<ref id="c13"><label>13.</label><mixed-citation publication-type="book"><person-group person-group-type="author"><collab>Global Burden of Disease Collaborative Network. Global Burden of Disease Study</collab></person-group> <year>2021</year> <source>(GBD 2021) Socio-Demographic Index (SDI) 1950–2021</source>. Seattle, <publisher-loc>United States of America</publisher-loc>: <publisher-name>Institute for Health Metrics and Evaluation</publisher-name> (IHME), 2024 [online]. Available from <ext-link ext-link-type="uri" xlink:href="https://ghdx.healthdata.org/record/global-burden-disease-study-2021-gbd-2021-socio-demographic-index-sdi-1950%E2%80%932021">https://ghdx.healthdata.org/record/global-burden-disease-study-2021-gbd-2021-socio-demographic-index-sdi-1950%E2%80%932021</ext-link> (Accessed 1st November 2024).</mixed-citation></ref>
<ref id="c14"><label>14.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tierney</surname> <given-names>JF</given-names></string-name>, <string-name><surname>Stewart</surname> <given-names>LA</given-names></string-name>, <string-name><surname>Ghersi</surname> <given-names>D</given-names></string-name>, <string-name><surname>Burdett</surname> <given-names>S</given-names></string-name>, <string-name><surname>Sydes</surname> <given-names>MR</given-names></string-name></person-group>. <article-title>Practical methods for incorporating summary time-to-event data into meta-analysis</article-title>. <source>Trials</source>. <year>2007</year> Jun 7;<volume>8</volume>:<issue>16</issue>. doi: <pub-id pub-id-type="doi">10.1186/1745-6215-8-16</pub-id>. PMID: <pub-id pub-id-type="pmid">17555582</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC1920534</pub-id>.</mixed-citation></ref>
<ref id="c15"><label>15.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Limenih</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Mekonnen</surname> <given-names>EG</given-names></string-name>, <string-name><surname>Birhanu</surname> <given-names>F</given-names></string-name>, <string-name><surname>Jima</surname> <given-names>BR</given-names></string-name>, <string-name><surname>Sisay</surname> <given-names>BG</given-names></string-name>, <string-name><surname>Kassahun</surname> <given-names>EA</given-names></string-name>, <string-name><surname>Hassen</surname> <given-names>HY</given-names></string-name></person-group>. <article-title>Survival Patterns Among Patients With Breast Cancer in Sub-Saharan Africa: A Systematic Review and Meta-Analysis</article-title>. <source>JAMA Netw Open</source>. <year>2024</year> May 1;<volume>7</volume>(<issue>5</issue>):<fpage>e2410260</fpage>. doi: <pub-id pub-id-type="doi">10.1001/jamanetworkopen.2024.10260</pub-id>. PMID: <pub-id pub-id-type="pmid">38743426</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC11094564</pub-id>.</mixed-citation></ref>
<ref id="c16"><label>16.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Langan</surname> <given-names>D</given-names></string-name>, <string-name><surname>Higgins</surname> <given-names>JPT</given-names></string-name>, <string-name><surname>Jackson</surname> <given-names>D</given-names></string-name>, <string-name><surname>Bowden</surname> <given-names>J</given-names></string-name>, <string-name><surname>Veroniki</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Kontopantelis</surname> <given-names>E</given-names></string-name>, <string-name><surname>Viechtbauer</surname> <given-names>W</given-names></string-name>, <string-name><surname>Simmonds</surname> <given-names>M</given-names></string-name></person-group>. <article-title>A comparison of heterogeneity variance estimators in simulated random-effects meta-analyses</article-title>. <source>Res Synth Methods</source>. <year>2019</year> <month>Mar</month>;<volume>10</volume>(<issue>1</issue>):<fpage>83</fpage>–<lpage>98</lpage>. doi: <pub-id pub-id-type="doi">10.1002/jrsm.1316</pub-id>. Epub 2018 Sep 6. PMID: <pub-id pub-id-type="pmid">30067315</pub-id>.</mixed-citation></ref>
<ref id="c17"><label>17.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tanriver-Ayder</surname> <given-names>E</given-names></string-name>, <string-name><surname>Faes</surname> <given-names>C</given-names></string-name>, <string-name><surname>van de Casteele</surname> <given-names>T</given-names></string-name>, <string-name><surname>McCann</surname> <given-names>SK</given-names></string-name>, <string-name><surname>Macleod</surname> <given-names>MR</given-names></string-name></person-group>. <article-title>Comparison of commonly used methods in random effects meta-analysis: application to preclinical data in drug discovery research</article-title>. <source>BMJ Open Sci</source>. <year>2021</year> <month>Feb</month> 25;<volume>5</volume>(<issue>1</issue>):<fpage>e100074</fpage>. doi: <pub-id pub-id-type="doi">10.1136/bmjos-2020-100074</pub-id>. PMID: <pub-id pub-id-type="pmid">35047696</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC8647574</pub-id>.</mixed-citation></ref>
<ref id="c18"><label>18.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Galukande</surname> <given-names>M</given-names></string-name>, <string-name><surname>Wabinga</surname> <given-names>H</given-names></string-name>, <string-name><surname>Mirembe</surname> <given-names>F</given-names></string-name></person-group>. <article-title>Breast cancer survival experiences at a tertiary hospital in sub-Saharan Africa: a cohort study</article-title>. <source>World J Surg Oncol</source>. <year>2015</year> <month>Jul</month> 19;<volume>13</volume>:<issue>220</issue>. doi: <pub-id pub-id-type="doi">10.1186/s12957-015-0632-4</pub-id>. PMID: <pub-id pub-id-type="pmid">26187151</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC4506617</pub-id>.</mixed-citation></ref>
<ref id="c19"><label>19.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gakwaya</surname> <given-names>A</given-names></string-name>, <string-name><surname>Kigula-Mugambe</surname> <given-names>JB</given-names></string-name>, <string-name><surname>Kavuma</surname> <given-names>A</given-names></string-name>, <string-name><surname>Luwaga</surname> <given-names>A</given-names></string-name>, <string-name><surname>Fualal</surname> <given-names>J</given-names></string-name>, <string-name><surname>Jombwe</surname> <given-names>J</given-names></string-name>, <string-name><surname>Galukande</surname> <given-names>M</given-names></string-name>, <string-name><surname>Kanyike</surname> <given-names>D</given-names></string-name></person-group>. <article-title>Cancer of the breast: 5-year survival in a tertiary hospital in Uganda</article-title>. <source>Br J Cancer</source>. <year>2008</year> <month>Jul</month> 8;<volume>99</volume>(<issue>1</issue>):<fpage>63</fpage>–<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1038/sj.bjc.6604435</pub-id>. Epub 2008 Jun 24. PMID: <pub-id pub-id-type="pmid">18577991</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC2453032</pub-id>.</mixed-citation></ref>
<ref id="c20"><label>20.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Thomas</surname> <given-names>AS</given-names></string-name>, <string-name><surname>Kidwell</surname> <given-names>KM</given-names></string-name>, <string-name><surname>Oppong</surname> <given-names>JK</given-names></string-name>, <string-name><surname>Adjei</surname> <given-names>EK</given-names></string-name>, <string-name><surname>Osei-Bonsu</surname> <given-names>E</given-names></string-name>, <string-name><surname>Boahene</surname> <given-names>A</given-names></string-name>, <string-name><surname>Jiggae</surname> <given-names>E</given-names></string-name>, <string-name><surname>Gyan</surname> <given-names>K</given-names></string-name>, <string-name><surname>Merajver</surname> <given-names>SD</given-names></string-name></person-group>. <article-title>Breast Cancer in Ghana: Demonstrating the Need for Population-Based Cancer Registries in Low-and Middle-Income Countries</article-title>. <source>J Glob Oncol</source>. <year>2017</year> <month>Dec</month>;<volume>3</volume>(<issue>6</issue>):<fpage>765</fpage>–<lpage>772</lpage>. doi: <pub-id pub-id-type="doi">10.1200/JGO.2016.006098</pub-id>. Epub 2017 Mar 27. PMID: <pub-id pub-id-type="pmid">29244986</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC5735963</pub-id>.</mixed-citation></ref>
<ref id="c21"><label>21.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Anele</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Bowling</surname> <given-names>M</given-names></string-name>, <string-name><surname>Eckert</surname> <given-names>GJ</given-names></string-name>, <string-name><surname>Gonzalez</surname> <given-names>E</given-names></string-name>, <string-name><surname>Kipfer</surname> <given-names>H</given-names></string-name>, <string-name><surname>Sauder</surname> <given-names>C</given-names></string-name></person-group>. <article-title>Treatment of Breast Cancer: Imo State Nigeria Versus Indiana, USA Women - Comparative Analytic Study</article-title>. <source>J West Afr Coll Surg</source>. <year>2014</year> Oct-Dec;4(4):39-69. PMID: <pub-id pub-id-type="pmid">27182510</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC4866729</pub-id>.</mixed-citation></ref>
<ref id="c22"><label>22.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Cubasch</surname> <given-names>H</given-names></string-name>, <string-name><surname>Dickens</surname> <given-names>C</given-names></string-name>, <string-name><surname>Joffe</surname> <given-names>M</given-names></string-name>, <string-name><surname>Duarte</surname> <given-names>R</given-names></string-name>, <string-name><surname>Murugan</surname> <given-names>N</given-names></string-name>, <string-name><surname>Tsai Chih</surname> <given-names>M</given-names></string-name>, <string-name><surname>Moodley</surname> <given-names>K</given-names></string-name>, <string-name><surname>Sharma</surname> <given-names>V</given-names></string-name>, <string-name><surname>Ayeni</surname> <given-names>O</given-names></string-name>, <string-name><surname>Jacobson</surname> <given-names>JS</given-names></string-name>, <string-name><surname>Neugut</surname> <given-names>AI</given-names></string-name>, <string-name><surname>McCormack</surname> <given-names>V</given-names></string-name>, <string-name><surname>Ruff</surname> <given-names>P</given-names></string-name></person-group>. <article-title>Breast cancer survival in Soweto, Johannesburg, South Africa: A receptor-defined cohort of women diagnosed from 2009 to 11</article-title>. <source>Cancer Epidemiol</source>. <year>2018</year> Feb;<volume>52</volume>:<fpage>120</fpage>-<lpage>127</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.canep.2017.12.007</pub-id>. Epub 2018 Jan 4. PMID: <pub-id pub-id-type="pmid">29306221</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC6127863</pub-id>.</mixed-citation></ref>
<ref id="c23"><label>23.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Eber-Schulz</surname> <given-names>P</given-names></string-name>, <string-name><surname>Tariku</surname> <given-names>W</given-names></string-name>, <string-name><surname>Reibold</surname> <given-names>C</given-names></string-name>, <string-name><surname>Addissie</surname> <given-names>A</given-names></string-name>, <string-name><surname>Wickenhauser</surname> <given-names>C</given-names></string-name>, <string-name><surname>Fathke</surname> <given-names>C</given-names></string-name>, <string-name><surname>Hauptmann</surname> <given-names>S</given-names></string-name>, <string-name><surname>Jemal</surname> <given-names>A</given-names></string-name>, <string-name><surname>Thomssen</surname> <given-names>C</given-names></string-name>, <string-name><surname>Kantelhardt</surname> <given-names>EJ</given-names></string-name></person-group>. <article-title>Survival of breast cancer patients in rural Ethiopia</article-title>. <source>Breast Cancer Res Treat</source>. <year>2018</year> Jul;<volume>170</volume>(<issue>1</issue>):<fpage>111</fpage>–<lpage>118</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10549-018-4724-z</pub-id>. Epub 2018 Feb 26. PMID: <pub-id pub-id-type="pmid">29479644</pub-id>.</mixed-citation></ref>
<ref id="c24"><label>24.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kantelhardt</surname> <given-names>EJ</given-names></string-name>, <string-name><surname>Zerche</surname> <given-names>P</given-names></string-name>, <string-name><surname>Mathewos</surname> <given-names>A</given-names></string-name>, <string-name><surname>Trocchi</surname> <given-names>P</given-names></string-name>, <string-name><surname>Addissie</surname> <given-names>A</given-names></string-name>, <string-name><surname>Aynalem</surname> <given-names>A</given-names></string-name>, <string-name><surname>Wondemagegnehu</surname> <given-names>T</given-names></string-name>, <string-name><surname>Ersumo</surname> <given-names>T</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Breast cancer survival in Ethiopia: a cohort study of 1,070 women</article-title>. <source>Int J Cancer</source>. <year>2014</year> Aug 1;<volume>135</volume>(<issue>3</issue>):<fpage>702</fpage>–<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ijc.28691</pub-id>. Epub 2014 Jan 10. PMID: <pub-id pub-id-type="pmid">24375396</pub-id>.</mixed-citation></ref>
<ref id="c25"><label>25.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Makanjuola</surname> <given-names>SB</given-names></string-name>, <string-name><surname>Popoola</surname> <given-names>AO</given-names></string-name>, <string-name><surname>Oludara</surname> <given-names>MA</given-names></string-name></person-group>. <article-title>Radiation therapy: a major factor in the five-year survival analysis of women with breast cancer in Lagos, Nigeria</article-title>. <source>Radiother Oncol</source>. <year>2014</year> <month>May</month>;<volume>111</volume>(<issue>2</issue>):<fpage>321</fpage>–<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.radonc.2014.03.013</pub-id>. Epub 2014 Apr 17. PMID: <pub-id pub-id-type="pmid">24746579</pub-id>.</mixed-citation></ref>
<ref id="c26"><label>26.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kene</surname> <given-names>TS</given-names></string-name>, <string-name><surname>Odigie</surname> <given-names>VI</given-names></string-name>, <string-name><surname>Yusufu</surname> <given-names>LM</given-names></string-name>, <string-name><surname>Yusuf</surname> <given-names>BO</given-names></string-name>, <string-name><surname>Shehu</surname> <given-names>SM</given-names></string-name>, <string-name><surname>Kase</surname> <given-names>JT</given-names></string-name></person-group>. <article-title>Pattern of presentation and survival of breast cancer in a teaching hospital in north Western Nigeria</article-title>. <source>Oman Med J</source>. <year>2010</year> <month>Apr</month>;<volume>25</volume>(<issue>2</issue>):<fpage>104</fpage>–<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.5001/omj.2010.29</pub-id>. PMID: <pub-id pub-id-type="pmid">22125710</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC3215495</pub-id>.</mixed-citation></ref>
<ref id="c27"><label>27.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ikpat</surname> <given-names>OF</given-names></string-name>, <string-name><surname>Ndoma-Egba</surname> <given-names>R</given-names></string-name>, <string-name><surname>Collan</surname> <given-names>Y</given-names></string-name></person-group>. <article-title>Influence of age and prognosis of breast cancer in Nigeria</article-title>. <source>East Afr Med J</source>. <year>2002</year> <month>Dec</month>;<volume>79</volume>(<issue>12</issue>):<fpage>651</fpage>–<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.4314/eamj.v79i12.8673</pub-id>. PMID: <pub-id pub-id-type="pmid">12678449</pub-id>.</mixed-citation></ref>
<ref id="c28"><label>28.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Souad</surname> <given-names>H</given-names></string-name>, <string-name><surname>Zahia</surname> <given-names>F</given-names></string-name>, <string-name><surname>Abdelhak</surname> <given-names>L</given-names></string-name>, <string-name><surname>Karima</surname> <given-names>S</given-names></string-name>, <string-name><surname>Dalila</surname> <given-names>S</given-names></string-name>, <string-name><surname>Noureddine</surname> <given-names>A</given-names></string-name></person-group>. <article-title>Descriptive study of triple negative breast cancer in Eastern Algeria</article-title>. <source>Pan Afr Med J</source>. <year>2018</year> Jan 18;<volume>29</volume>:<issue>45</issue>. doi: <pub-id pub-id-type="doi">10.11604/pamj.2018.29.45.12523</pub-id>. PMID: <pub-id pub-id-type="pmid">29875927</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC5987100</pub-id>.</mixed-citation></ref>
<ref id="c29"><label>29.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ismail</surname> <given-names>A</given-names></string-name>, <string-name><surname>El-Awady</surname> <given-names>R</given-names></string-name>, <string-name><surname>Mohamed</surname> <given-names>G</given-names></string-name>, <string-name><surname>Hussein</surname> <given-names>M</given-names></string-name>, <string-name><surname>Ramadan</surname> <given-names>SS</given-names></string-name></person-group>. <article-title>Prognostic Significance of Serum Vitamin D Levels in Egyptian Females with Breast Cancer</article-title>. <source>Asian Pac J Cancer Prev</source>. <year>2018</year> Feb 26;<volume>19</volume>(<issue>2</issue>):<fpage>571</fpage>–<lpage>576</lpage>. doi: <pub-id pub-id-type="doi">10.22034/APJCP.2018.19.2.571</pub-id>. PMID: <pub-id pub-id-type="pmid">29481024</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC5980952</pub-id>.</mixed-citation></ref>
<ref id="c30"><label>30.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bogan</surname> <given-names>D</given-names></string-name>, <string-name><surname>Meile</surname> <given-names>L</given-names></string-name>, <string-name><surname>El Bastawisy</surname> <given-names>A</given-names></string-name>, <string-name><surname>Yousef</surname> <given-names>HF</given-names></string-name>, <string-name><surname>Zekri</surname> <given-names>AN</given-names></string-name>, <string-name><surname>Bahnassy</surname> <given-names>AA</given-names></string-name>, <string-name><surname>ElShamy</surname> <given-names>WM</given-names></string-name></person-group>. <article-title>The role of BRCA1-IRIS in the development and progression of triple negative breast cancers in Egypt: possible link to disease early lesion</article-title>. <source>BMC Cancer</source>. <year>2017</year> <month>May</month> 12;<volume>17</volume>(<issue>1</issue>):<fpage>329</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12885-017-3283-8</pub-id>. PMID: <pub-id pub-id-type="pmid">28499366</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC5429567</pub-id>.</mixed-citation></ref>
<ref id="c31"><label>31.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Aiad</surname> <given-names>HA</given-names></string-name>, <string-name><surname>Kandil</surname> <given-names>MA</given-names></string-name>, <string-name><surname>El-Tahmody</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Abulkheir</surname> <given-names>IL</given-names></string-name>, <string-name><surname>Abulkasem</surname> <given-names>FM</given-names></string-name>, <string-name><surname>Elmansori</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Aleskandarany</surname> <given-names>MA</given-names></string-name></person-group>. <article-title>The prognostic and predictive significance of PARP-1 in locally advanced breast cancer of Egyptian patients receiving neoadjuvant chemotherapy</article-title>. <source>Appl Immunohistochem Mol Morphol</source>. <year>2015</year> Sep;<volume>23</volume>(<issue>8</issue>):<fpage>571</fpage>–<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1097/PAI.0000000000000124</pub-id>. PMID: <pub-id pub-id-type="pmid">25611238</pub-id>.</mixed-citation></ref>
<ref id="c32"><label>32.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Taha</surname> <given-names>FM</given-names></string-name>, <string-name><surname>Zeeneldin</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Helal</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Gaber</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Sallam</surname> <given-names>YA</given-names></string-name>, <string-name><surname>Ramadan</surname> <given-names>H</given-names></string-name>, <string-name><surname>Moneer</surname> <given-names>MM</given-names></string-name></person-group>. <article-title>Prognostic value of serum vascular endothelial growth factor in Egyptian females with metastatic triple negative breast cancer</article-title>. <source>Clin Biochem</source>. <year>2009</year> <month>Sep</month>;<volume>42</volume>(<issue>13-14</issue>):<fpage>1420</fpage>–<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.clinbiochem.2009.06.022</pub-id>. Epub 2009 Jul 2. PMID: <pub-id pub-id-type="pmid">19576877</pub-id>.</mixed-citation></ref>
<ref id="c33"><label>33.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zeeneldin</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Mohamed</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Abdel</surname> <given-names>HA</given-names></string-name>, <string-name><surname>Taha</surname> <given-names>FM</given-names></string-name>, <string-name><surname>Goda</surname> <given-names>IA</given-names></string-name>, <string-name><surname>Abodeef</surname> <given-names>WT</given-names></string-name></person-group>. <article-title>Survival effects of cyclooxygenase-2 and 12-lipooxygenase in Egyptian women with operable breast cancer</article-title>. <source>Indian J Cancer</source>. <year>2009</year> Jan-Mar;46(1):54-60. doi: <pub-id pub-id-type="doi">10.4103/0019-509x.48597</pub-id>. PMID: <pub-id pub-id-type="pmid">19282568</pub-id>.</mixed-citation></ref>
<ref id="c34"><label>34.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Slaoui</surname> <given-names>M</given-names></string-name>, <string-name><surname>Mouh</surname> <given-names>FZ</given-names></string-name>, <string-name><surname>Ghanname</surname> <given-names>I</given-names></string-name>, <string-name><surname>Razine</surname> <given-names>R</given-names></string-name>, <string-name><surname>El Mzibri</surname> <given-names>M</given-names></string-name>, <string-name><surname>Amrani</surname> <given-names>M</given-names></string-name></person-group>. <article-title>Outcome of Breast Cancer in Moroccan Young Women Correlated to Clinic-Pathological Features, Risk Factors and Treatment: A Comparative Study of 716 Cases in a Single Institution</article-title>. <source>PLoS One</source>. <year>2016</year> Oct 19;11(10):e0164841. doi: <pub-id pub-id-type="doi">10.1371/journal.pone.0164841</pub-id>. PMID: <pub-id pub-id-type="pmid">27760178</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC5070817</pub-id>.</mixed-citation></ref>
<ref id="c35"><label>35.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ermiah</surname> <given-names>E</given-names></string-name>, <string-name><surname>Buhmeida</surname> <given-names>A</given-names></string-name>, <string-name><surname>Khaled</surname> <given-names>BR</given-names></string-name>, <string-name><surname>Abdalla</surname> <given-names>F</given-names></string-name>, <string-name><surname>Salem</surname> <given-names>N</given-names></string-name>, <string-name><surname>Pyrhönen</surname> <given-names>S</given-names></string-name>, <string-name><surname>Collan</surname> <given-names>Y</given-names></string-name></person-group>. <article-title>Prognostic value of bcl-2 expression among women with breast cancer in Libya</article-title>. <source>Tumour Biol</source>. <year>2013</year> Jun;<volume>34</volume>(<issue>3</issue>):<fpage>1569</fpage>–<lpage>78</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s13277-013-0687-1</pub-id>. Epub 2013 Feb 16. PMID: <pub-id pub-id-type="pmid">23417836</pub-id>.</mixed-citation></ref>
<ref id="c36"><label>36.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ngowa</surname> <given-names>JDK</given-names></string-name>, <string-name><surname>Kasia</surname> <given-names>JM</given-names></string-name>, <string-name><surname>Yomi</surname> <given-names>J</given-names></string-name>, <string-name><surname>Nana</surname> <given-names>AN</given-names></string-name>, <string-name><surname>Ngassam</surname> <given-names>A</given-names></string-name>, <string-name><surname>Domkam</surname> <given-names>I</given-names></string-name>, <string-name><surname>Sando</surname> <given-names>Z</given-names></string-name>, <string-name><surname>Ndom</surname> <given-names>P</given-names></string-name></person-group>. <article-title>Breast Cancer Survival in Cameroon: Analysis of a Cohort of 404 Patients at the Yaoundé General Hospital</article-title>. <source>Advances in Breast Cancer Research</source>. <year>2015</year>;<volume>4</volume>(<issue>2</issue>):<fpage>44</fpage>–<lpage>52</lpage>. doi: <pub-id pub-id-type="doi">10.4236/abcr.2015.42005</pub-id>.</mixed-citation></ref>
<ref id="c37"><label>37.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Abdalla</surname> <given-names>FB</given-names></string-name>, <string-name><surname>Markus</surname> <given-names>R</given-names></string-name>, <string-name><surname>Buhmeida</surname> <given-names>A</given-names></string-name>, <string-name><surname>Boder</surname> <given-names>J</given-names></string-name>, <string-name><surname>Syrjänen</surname> <given-names>K</given-names></string-name>, <string-name><surname>Collan</surname> <given-names>Y</given-names></string-name></person-group>. <article-title>Estrogen receptor, progesterone receptor, and nuclear size features in female breast cancer in Libya: correlation with clinical features and survival</article-title>. <source>Anticancer Res</source>. <year>2012</year> <month>Aug</month>;<volume>32</volume>(<issue>8</issue>):<fpage>3485</fpage>–<lpage>93</lpage>. PMID: <pub-id pub-id-type="pmid">22843935</pub-id>.</mixed-citation></ref>
<ref id="c38"><label>38.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>Ben</given-names> <surname>Ahmed S</surname></string-name>, <string-name><surname>Aloulou</surname> <given-names>S</given-names></string-name>, <string-name><surname>Bibi</surname> <given-names>M</given-names></string-name>, <string-name><surname>Landolsi</surname> <given-names>A</given-names></string-name>, <string-name><surname>Nouira</surname> <given-names>M</given-names></string-name>, <string-name><surname>Ben Fatma</surname> <given-names>L</given-names></string-name>, <string-name><surname>Kallel</surname> <given-names>L</given-names></string-name>, <string-name><surname>Gharbi</surname> <given-names>O</given-names></string-name>, <string-name><surname>Korbi</surname> <given-names>S</given-names></string-name>, <string-name><surname>Khaïri</surname> <given-names>H</given-names></string-name>, <string-name><surname>Kraïem</surname> <given-names>C</given-names></string-name></person-group>. <article-title>Pronostic du cancer du sein chez les femmes tunisiennes: analyse d’une série hospitalière de 729 patientes [Breast cancer prognosis in Tunisian women: analysis of a hospital series of 729 patients]</article-title>. <source>Sante Publique</source>. <year>2002</year> <month>Sep</month>;<volume>14</volume>(<issue>3</issue>):<fpage>231</fpage>–<lpage>41</lpage>. French. PMID: <pub-id pub-id-type="pmid">12564048</pub-id>.</mixed-citation></ref>
<ref id="c39"><label>39.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Samaka</surname> <given-names>RM</given-names></string-name>, <string-name><surname>Younes</surname> <given-names>SF</given-names></string-name></person-group>. <article-title>Androgen Receptor Expression in Breast Carcinoma of Egyptian Patients</article-title>. <source>J Clin Diagn Res</source>. <year>2016</year> <month>Nov</month>;<volume>10</volume>(<issue>11</issue>):<fpage>EC17</fpage>-<lpage>EC21</lpage>. doi: <pub-id pub-id-type="doi">10.7860/JCDR/2016/23364.8919</pub-id>. Epub 2016 Nov 1. PMID: <pub-id pub-id-type="pmid">28050375</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC5198328</pub-id>.</mixed-citation></ref>
<ref id="c40"><label>40.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Derkaoui</surname> <given-names>T</given-names></string-name>, <string-name><surname>Bakkach</surname> <given-names>J</given-names></string-name>, <string-name><surname>Mansouri</surname> <given-names>M</given-names></string-name>, <string-name><surname>Loudiyi</surname> <given-names>A</given-names></string-name>, <string-name><surname>Fihri</surname> <given-names>M</given-names></string-name>, <string-name><surname>Alaoui</surname> <given-names>FZ</given-names></string-name>, <string-name><surname>Barakat</surname> <given-names>A</given-names></string-name>, <string-name><surname>El Yemlahi</surname> <given-names>B</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Triple negative breast cancer in North of Morocco: clinicopathologic and prognostic features</article-title>. <source>BMC Womens Health</source>. <year>2016</year> Oct 22;<volume>16</volume>(<issue>1</issue>):<fpage>68</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12905-016-0346-y</pub-id>. PMID: <pub-id pub-id-type="pmid">27770782</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC5075166</pub-id>.</mixed-citation></ref>
<ref id="c41"><label>41.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Traore</surname> <given-names>B</given-names></string-name>, <string-name><surname>Toure</surname> <given-names>A</given-names></string-name>, <string-name><surname>Sy</surname> <given-names>T</given-names></string-name>, <string-name><surname>Dieng</surname> <given-names>MM</given-names></string-name>, <string-name><surname>Conde</surname> <given-names>M</given-names></string-name>, <string-name><surname>Dem</surname> <given-names>A</given-names></string-name>, <string-name><surname>Keita</surname> <given-names>N</given-names></string-name>, <string-name><surname>Sylla</surname> <given-names>BS</given-names></string-name></person-group>. <article-title>Five-year prognosis of breast cancer patients in Conakry Hospital University (West Africa)</article-title>. <source>J Clin Oncol</source>. <year>2015</year>;<volume>33</volume>(<issue>15_Suppl</issue>):<elocation-id>e12065</elocation-id>. doi: <pub-id pub-id-type="doi">10.1200/jco.2015.33.15_suppl.e12065</pub-id>.</mixed-citation></ref>
<ref id="c42"><label>42.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ayoade</surname> <given-names>BA</given-names></string-name>, <string-name><surname>Agboola</surname> <given-names>AJ</given-names></string-name>, <string-name><surname>Olatunji</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Tade</surname> <given-names>AO</given-names></string-name>, <string-name><surname>Salami</surname> <given-names>BA</given-names></string-name>, <string-name><surname>Adekoya</surname> <given-names>AO</given-names></string-name></person-group>. <article-title>Clinical characteristics and survival outcome of breast cancer in southwest Nigerian women</article-title>. <source>J Afr Cancer</source>. <year>2014</year>;<volume>6</volume>:<fpage>79</fpage>–<lpage>84</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12558-014-0311-8</pub-id>.</mixed-citation></ref>
<ref id="c43"><label>43.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zeeneldin</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Ramadan</surname> <given-names>M</given-names></string-name>, <string-name><surname>Elmashad</surname> <given-names>N</given-names></string-name>, <string-name><surname>Fakhr</surname> <given-names>I</given-names></string-name>, <string-name><surname>Diaa</surname> <given-names>A</given-names></string-name>, <string-name><surname>Mosaad</surname> <given-names>E</given-names></string-name></person-group>. <article-title>Breast cancer laterality among Egyptian patients and its association with treatments and survival</article-title>. <source>J Egypt Natl Canc Inst</source>. <year>2013</year> <month>Dec</month>;<volume>25</volume>(<issue>4</issue>):<fpage>199</fpage>–<lpage>207</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jnci.2013.09.003</pub-id>. Epub 2013 Oct 25. PMID: <pub-id pub-id-type="pmid">24207092</pub-id>.</mixed-citation></ref>
<ref id="c44"><label>44.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mohammad</surname> <given-names>MA</given-names></string-name>, <string-name><surname>Zeeneldin</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Abd Elmageed</surname> <given-names>ZY</given-names></string-name>, <string-name><surname>Khalil</surname> <given-names>EH</given-names></string-name>, <string-name><surname>Mahdy</surname> <given-names>SM</given-names></string-name>, <string-name><surname>Sharada</surname> <given-names>HM</given-names></string-name>, <string-name><surname>Sharawy</surname> <given-names>SK</given-names></string-name>, <string-name><surname>Abdel-Wahab</surname> <given-names>AH</given-names></string-name></person-group>. <article-title>Clinical relevance of cyclooxygenase-2 and matrix metalloproteinases (MMP-2 and MT1-MMP) in human breast cancer tissue</article-title>. <source>Mol Cell Biochem</source>. <year>2012</year> Jul;<volume>366</volume>(<issue>1-2</issue>):<fpage>269</fpage>–<lpage>75</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11010-012-1305-z</pub-id>. Epub 2012 Apr 18. PMID: <pub-id pub-id-type="pmid">22527932</pub-id>.</mixed-citation></ref>
<ref id="c45"><label>45.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kantelhardt</surname> <given-names>EJ</given-names></string-name>, <string-name><surname>Zerche</surname> <given-names>P</given-names></string-name>, <string-name><surname>Trocchi</surname> <given-names>P</given-names></string-name>, <string-name><surname>Mathios</surname> <given-names>A</given-names></string-name>, <string-name><surname>Reeler</surname> <given-names>A</given-names></string-name>, <string-name><surname>Tufa</surname> <given-names>G</given-names></string-name>, <string-name><surname>Yonas</surname> <given-names>B</given-names></string-name>, <string-name><surname>Stang</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Breast cancer in Sub-Saharan Africa: 1,000 patients with primary breast cancer in Addis Ababa followed for up to 5 years</article-title>. <source>J Clin Oncol</source>. <year>2012</year>;<volume>30</volume>(<issue>15_Suppl</issue>):<elocation-id>580</elocation-id>. doi: <pub-id pub-id-type="doi">10.1200/jco.2012.30.15_suppl.580</pub-id>.</mixed-citation></ref>
<ref id="c46"><label>46.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Seedhom</surname> <given-names>AE</given-names></string-name>, <string-name><surname>Kamal</surname> <given-names>NN</given-names></string-name></person-group>. <article-title>Factors affecting survival of women diagnosed with breast cancer in El-Minia Governorate, Egypt</article-title>. <source>Int J Prev Med</source>. <year>2011</year> <month>Jul</month>;<volume>2</volume>(<issue>3</issue>):<fpage>131</fpage>–<lpage>8</lpage>. PMID: <pub-id pub-id-type="pmid">21811654</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC3143525</pub-id>.</mixed-citation></ref>
<ref id="c47"><label>47.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>El</given-names> <surname>Mongy M</surname></string-name>, <string-name><given-names>El</given-names> <surname>Hossieny H</surname></string-name>, <string-name><surname>Haggag</surname> <given-names>F</given-names></string-name>, <string-name><surname>Fathy</surname> <given-names>R</given-names></string-name></person-group>. <article-title>Clinico-pathological study and treatment results of 1009 operable breast cancer cases: Experience of NCI Cairo University</article-title>, <source>Egypt. Chin.-Ger. J. Clin. Oncol</source>. <year>2010</year>; <volume>9</volume>:<fpage>409</fpage>–<lpage>415</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10330-010-0614-5</pub-id>.</mixed-citation></ref>
<ref id="c48"><label>48.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sankaranarayanan</surname> <given-names>R</given-names></string-name>, <string-name><surname>Swaminathan</surname> <given-names>R</given-names></string-name>, <string-name><surname>Brenner</surname> <given-names>H</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>K</given-names></string-name>, <string-name><surname>Chia</surname> <given-names>KS</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>JG</given-names></string-name>, <string-name><surname>Law</surname> <given-names>SC</given-names></string-name>, <string-name><surname>Ahn</surname> <given-names>YO</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Cancer survival in Africa, Asia, and Central America: a population-based study</article-title>. <source>Lancet Oncol</source>. <year>2010</year> <month>Feb</month>;<volume>11</volume>(<issue>2</issue>):<fpage>165</fpage>–<lpage>73</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S1470-2045(09)70335-3</pub-id>. Epub 2009 Dec 10. PMID: <pub-id pub-id-type="pmid">20005175</pub-id>.</mixed-citation></ref>
<ref id="c49"><label>49.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kaabia</surname> <given-names>O</given-names></string-name>, <string-name><surname>Amine</surname> <given-names>G</given-names></string-name>, <string-name><surname>Nawel</surname> <given-names>A</given-names></string-name>, <string-name><surname>Feten</surname> <given-names>H</given-names></string-name>, <string-name><surname>Afraa</surname> <given-names>B</given-names></string-name></person-group>. <article-title>Male Breast Cancer in Tunisia: Epidemiological and Clinical Features &amp; Prognosis Factors</article-title>. <source>International Journal of Gynecological Cancer</source>. <year>2017</year>;<volume>27</volume>(November Suppl 4):631 (ESGO7-1121). doi: <pub-id pub-id-type="doi">10.1097/01.IGC.0000527296.86225.87</pub-id>.</mixed-citation></ref>
<ref id="c50"><label>50.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>Alaoui</given-names> <surname>Slimani K</surname></string-name>, <string-name><surname>Debbagh</surname> <given-names>A</given-names></string-name>, <string-name><surname>Sbitti</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Errihani</surname> <given-names>H</given-names></string-name>, <string-name><surname>Ichou</surname> <given-names>M</given-names></string-name></person-group>. <article-title>Cancer du sein chez l’homme au Maroc: épidémiologie et facteurs pronostiques. À propos de 140 cas [Male breast cancer in Morocco: Epidemiology and prognostic factors. A report of 140 cases]</article-title>. <source>Gynecol Obstet Fertil.</source> <year>2016</year> Nov;<volume>44</volume>(<issue>11</issue>):<fpage>636</fpage>-<lpage>640</lpage>. French. doi: <pub-id pub-id-type="doi">10.1016/j.gyobfe.2016.08.009</pub-id>. Epub 2016 Sep 23. PMID: <pub-id pub-id-type="pmid">27671207</pub-id>.</mixed-citation></ref>
<ref id="c51"><label>51.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>El-Beshbeshi</surname> <given-names>W</given-names></string-name>, <string-name><surname>Abo-Elnaga</surname> <given-names>EM</given-names></string-name></person-group>. <article-title>Male breast cancer: 10-year experience at mansoura university hospital in egypt</article-title>. <source>Cancer Biol Med</source>. <year>2012</year> <month>Mar</month>;<volume>9</volume>(<issue>1</issue>):<fpage>23</fpage>–<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.3969/j.issn.2095-3941.2012.01.004</pub-id>. PMID: <pub-id pub-id-type="pmid">23691450</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC3643641</pub-id>.</mixed-citation></ref>
<ref id="c52"><label>52.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>El-Baradie</surname> <given-names>M</given-names></string-name>, <string-name><surname>Salama</surname> <given-names>A</given-names></string-name>, <string-name><surname>Khorshid</surname> <given-names>O</given-names></string-name>, <string-name><surname>Ismail</surname> <given-names>H</given-names></string-name>, <string-name><surname>Attia</surname> <given-names>G</given-names></string-name>, <string-name><surname>Abeer</surname> <given-names>A</given-names></string-name></person-group>. <article-title>Egyptian male breast carcinoma: patients’ hormonal profile, management and outcome. Chin.-Ger</article-title>. <source>J. Clin. Oncol</source>. <year>2012</year>; <volume>11</volume>:<fpage>89</fpage>–<lpage>98</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s10330-011-0918-0</pub-id>.</mixed-citation></ref>
<ref id="c53"><label>53.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bourhafour</surname> <given-names>M</given-names></string-name>, <string-name><surname>Belbaraka</surname> <given-names>R</given-names></string-name>, <string-name><surname>Souadka</surname> <given-names>A</given-names></string-name>, <string-name><surname>M’rabti</surname> <given-names>H</given-names></string-name>, <string-name><surname>Tijami</surname> <given-names>F</given-names></string-name>, <string-name><surname>Errihani</surname> <given-names>H</given-names></string-name></person-group>. <article-title>Male breast cancer: a report of 127 cases at a Moroccan institution</article-title>. <source>BMC Res Notes</source>. <year>2011</year> Jun 29;<volume>4</volume>:<issue>219</issue>. doi: <pub-id pub-id-type="doi">10.1186/1756-0500-4-219</pub-id>. PMID: <pub-id pub-id-type="pmid">21714875</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC3143075</pub-id>.</mixed-citation></ref>
<ref id="c54"><label>54.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ihekwaba</surname> <given-names>FN</given-names></string-name></person-group>. <article-title>The management of male breast cancer in Nigerians</article-title>. <source>Postgrad Med J</source>. <year>1993</year> Jul;<volume>69</volume>(<issue>813</issue>):<fpage>562</fpage>–<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.1136/pgmj.69.813.562</pub-id>. PMID: <pub-id pub-id-type="pmid">8415345</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC2399872</pub-id>.</mixed-citation></ref>
<ref id="c55"><label>55.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bouzid</surname> <given-names>N</given-names></string-name>, <string-name><surname>Lahmar</surname> <given-names>R</given-names></string-name>, <string-name><surname>Tebra</surname> <given-names>S</given-names></string-name>, <string-name><surname>Bouaouina</surname> <given-names>N</given-names></string-name></person-group>. <article-title>Cancer du sein chez la femme jeune de moins de 35 ans en Tunisie: étude rétrospective à propos de 124 cas [Breast cancer in woman younger than 35 years in Tunisia: retrospective study about 124 cases]</article-title>. <source>Gynecol Obstet Fertil</source>. <year>2013</year> Jun;<volume>41</volume>(<issue>6</issue>):<fpage>356</fpage>–<lpage>60</lpage>. French. doi: <pub-id pub-id-type="doi">10.1016/j.gyobfe.2013.05.002</pub-id>. Epub 2013 Jun 7. PMID: <pub-id pub-id-type="pmid">23747138</pub-id>.</mixed-citation></ref>
<ref id="c56"><label>56.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Khanfir</surname> <given-names>A</given-names></string-name>, <string-name><surname>Frikha</surname> <given-names>M</given-names></string-name>, <string-name><surname>Kallel</surname> <given-names>F</given-names></string-name>, <string-name><surname>Meziou</surname> <given-names>M</given-names></string-name>, <string-name><surname>Trabelsi</surname> <given-names>K</given-names></string-name>, <string-name><surname>Boudawara</surname> <given-names>T</given-names></string-name>, <string-name><surname>Mnif</surname> <given-names>J</given-names></string-name>, <string-name><surname>Daoud</surname> <given-names>J</given-names></string-name></person-group>. <article-title>Le cancer du sein de la femme jeune dans le sud tunisien [Breast cancer in young women in the south of Tunisia]</article-title>. <source>Cancer Radiother</source>. <year>2006</year> <month>Dec</month>;<volume>10</volume>(<issue>8</issue>):<fpage>565</fpage>–<lpage>71</lpage>. French. doi: <pub-id pub-id-type="doi">10.1016/j.canrad.2006.09.115</pub-id>. Epub 2006 Nov 30. PMID: <pub-id pub-id-type="pmid">17140835</pub-id>.</mixed-citation></ref>
<ref id="c57"><label>57.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bakkach</surname> <given-names>J</given-names></string-name>, <string-name><surname>Mansouri</surname> <given-names>M</given-names></string-name>, <string-name><surname>Derkaoui</surname> <given-names>T</given-names></string-name>, <string-name><surname>Loudiyi</surname> <given-names>A</given-names></string-name>, <string-name><surname>Fihri</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hassani</surname> <given-names>S</given-names></string-name>, <string-name><surname>Barakat</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ghailani Nourouti</surname> <given-names>N</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Clinicopathologic and prognostic features of breast cancer in young women: a series from North of Morocco</article-title>. <source>BMC Womens Health</source>. <year>2017</year> Nov 9;<volume>17</volume>(<issue>1</issue>):<fpage>106</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12905-017-0456-1</pub-id>. PMID: <pub-id pub-id-type="pmid">29121898</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC5680801</pub-id>.</mixed-citation></ref>
<ref id="c58"><label>58.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>Ben</given-names> <surname>Abdelkrim S</surname></string-name>, <string-name><surname>Fathallah</surname> <given-names>K</given-names></string-name>, <string-name><surname>Rouatbi</surname> <given-names>R</given-names></string-name>, <string-name><surname>Ayachi</surname> <given-names>M</given-names></string-name>, <string-name><surname>Hmissa</surname> <given-names>S</given-names></string-name>, <string-name><surname>Mokni</surname> <given-names>M</given-names></string-name></person-group>. <article-title>Om.breast cancer in very young women aged 25 year-old or below in the center of Tunisia and review of the literature</article-title>. <source>Pathol Oncol Res</source>. <year>2015</year> <month>Jul</month>;<volume>21</volume>(<issue>3</issue>):<fpage>553</fpage>–<lpage>61</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s12253-015-9944-5</pub-id>. Epub 2015 May 12. PMID: <pub-id pub-id-type="pmid">25962349</pub-id>.</mixed-citation></ref>
<ref id="c59"><label>59.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Kallel</surname> <given-names>M</given-names></string-name>, <string-name><surname>Elloumi</surname> <given-names>F</given-names></string-name>, <string-name><surname>Khabir</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ghorbal</surname> <given-names>L</given-names></string-name>, <string-name><surname>Chaabouni</surname> <given-names>S</given-names></string-name>, <string-name><surname>Amouri</surname> <given-names>H</given-names></string-name>, <string-name><surname>Frikha</surname> <given-names>M</given-names></string-name>, <string-name><surname>Daoud</surname> <given-names>J</given-names></string-name></person-group>. <article-title>Breast cancer in young women in southern Tunisia: Anatomical study and clinical prognostic factors: About a series of 83 patients</article-title>. <source>Rep Pract Oncol Radiother</source>. <year>2015</year> <month>May</month>-Jun;20(3):155-60. doi: <pub-id pub-id-type="doi">10.1016/j.rpor.2015.01.007</pub-id>. Epub 2015 Mar 6. PMID: <pub-id pub-id-type="pmid">25949218</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC4418592</pub-id>.</mixed-citation></ref>
<ref id="c60"><label>60.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Khelifi</surname> <given-names>O</given-names></string-name>, <string-name><surname>Zeghal</surname> <given-names>D</given-names></string-name>, <string-name><surname>Jeridi</surname> <given-names>S</given-names></string-name>, <string-name><surname>Ben Hmid</surname> <given-names>R</given-names></string-name>, <string-name><surname>Zouari</surname> <given-names>F</given-names></string-name>, <string-name><surname>Mahjoub</surname> <given-names>S</given-names></string-name></person-group>. <article-title>Young women’s breast cancer</article-title>. <source>International Journal of Gynecology and Obstetrics</source>. <year>2012</year>;<volume>119</volume>(<issue>Suppl_3</issue>):<elocation-id>S630</elocation-id> (M307). doi: <pub-id pub-id-type="doi">10.1016/S0020-7292(12)61498-2</pub-id>.</mixed-citation></ref>
<ref id="c61"><label>61.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Basro</surname> <given-names>S</given-names></string-name>, <string-name><surname>Apffelstaedt</surname> <given-names>JP</given-names></string-name></person-group>. <article-title>Breast cancer in young women in a limited-resource environment</article-title>. <source>World J Surg</source>. <year>2010</year> <month>Jul</month>;<volume>34</volume>(<issue>7</issue>):<fpage>1427</fpage>–<lpage>33</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00268-009-0299-5</pub-id>. PMID: <pub-id pub-id-type="pmid">19997919</pub-id>.</mixed-citation></ref>
<ref id="c62"><label>62.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Parag</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Buccimazza</surname> <given-names>I</given-names></string-name></person-group>. <article-title>How long are elderly patients followed up with mammography after the diagnosis of breast cancer? A single-centre experience in a developing country</article-title>. <source>S Afr Med J</source>. <year>2016</year> <month>Jun</month> 17;<volume>106</volume>(<issue>7</issue>):<fpage>721</fpage>–<lpage>3</lpage>. doi: <pub-id pub-id-type="doi">10.7196/SAMJ.2016.v106i7.10405</pub-id>. PMID: <pub-id pub-id-type="pmid">27384369</pub-id>.</mixed-citation></ref>
<ref id="c63"><label>63.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zongo</surname> <given-names>N</given-names></string-name>, <string-name><surname>Ouédraogo</surname> <given-names>S</given-names></string-name>, <string-name><surname>Korsaga-Somé</surname> <given-names>N</given-names></string-name>, <string-name><surname>Somé</surname> <given-names>OR</given-names></string-name>, <string-name><surname>Go</surname> <given-names>N</given-names></string-name>, <string-name><surname>Ouangré</surname> <given-names>E</given-names></string-name>, <string-name><surname>Zida</surname> <given-names>M</given-names></string-name>, <string-name><surname>Bonkoungou</surname> <given-names>G</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Male breast cancer: diagnosis stages, treatment and survival in a country with limited resources (Burkina Faso)</article-title>. <source>World J Surg Oncol</source>. <year>2018</year> <month>Jan</month> 11;<volume>16</volume>(<issue>1</issue>):<fpage>4</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12957-017-1297-y</pub-id>. PMID: <pub-id pub-id-type="pmid">29325566</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC5765600</pub-id>.</mixed-citation></ref>
<ref id="c64"><label>64.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ahmed</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ukwenya</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Abdullahi</surname> <given-names>A</given-names></string-name>, <string-name><surname>Muhammad</surname> <given-names>I</given-names></string-name></person-group>. <article-title>Management and outcomes of male breast cancer in zaria, Nigeria</article-title>. <source>Int J Breast Cancer</source>. <year>2012</year>;2012:<volume>845143</volume>. doi: <pub-id pub-id-type="doi">10.1155/2012/845143</pub-id>. Epub 2012 Sep 6. PMID: <pub-id pub-id-type="pmid">22991670</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC3443591</pub-id>.</mixed-citation></ref>
<ref id="c65"><label>65.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Elshafiey</surname> <given-names>MM</given-names></string-name>, <string-name><surname>Zeeneldin</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Elsebai</surname> <given-names>HI</given-names></string-name>, <string-name><surname>Moneer</surname> <given-names>M</given-names></string-name>, <string-name><surname>Mohamed</surname> <given-names>DB</given-names></string-name>, <string-name><surname>Gouda</surname> <given-names>I</given-names></string-name>, <string-name><surname>Attia</surname> <given-names>AA</given-names></string-name></person-group>. <article-title>Epidemiology and management of breast carcinoma in Egyptian males: experience of a single Cancer Institute</article-title>. <source>J Egypt Natl Canc Inst</source>. <year>2011</year> <month>Sep</month>;<volume>23</volume>(<issue>3</issue>):<fpage>115</fpage>–<lpage>22</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.jnci.2011.10.001</pub-id>. Epub 2011 Nov 18. PMID: <pub-id pub-id-type="pmid">22776816</pub-id>.</mixed-citation></ref>
<ref id="c66"><label>66.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>El-Habbash</surname> <given-names>MM</given-names></string-name>, <string-name><surname>Alwindi</surname> <given-names>AA</given-names></string-name></person-group>. <article-title>Male breast cancer in Tripoli, Libya</article-title>. <source>Saudi Med J</source>. <year>2009</year> <month>Aug</month>;<volume>30</volume>(<issue>8</issue>):<fpage>1060</fpage>–<lpage>2</lpage>. PMID: <pub-id pub-id-type="pmid">19668888</pub-id>.</mixed-citation></ref>
<ref id="c67"><label>67.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>Ben</given-names> <surname>Dhiab T</surname></string-name>, <string-name><surname>Bouzid</surname> <given-names>T</given-names></string-name>, <string-name><surname>Gamoudi</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ben Hassouna</surname> <given-names>J</given-names></string-name>, <string-name><surname>Khomsi</surname> <given-names>F</given-names></string-name>, <string-name><surname>Boussen</surname> <given-names>H</given-names></string-name>, <string-name><surname>Benna</surname> <given-names>F</given-names></string-name>, <string-name><surname>El May</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Le cancer du sein chez l’homme: à propos de 123 cas colligés à l’institut Salah-Azaïz de Tunis de 1979 à 1999 [Male breast cancer: about 123 cases collected at the Institute Salah-Azaiz of Tunis from 1979 to 1999]</article-title>. <source>Bull Cancer</source>. <year>2005</year> <month>Mar</month>;<volume>92</volume>(<issue>3</issue>):<fpage>281</fpage>–<lpage>5</lpage>. French. PMID: <pub-id pub-id-type="pmid">15820923</pub-id>.</mixed-citation></ref>
<ref id="c68"><label>68.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tabbane</surname> <given-names>F</given-names></string-name>, <string-name><surname>Muenz</surname> <given-names>L</given-names></string-name>, <string-name><surname>Jaziri</surname> <given-names>M</given-names></string-name>, <string-name><surname>Cammoun</surname> <given-names>M</given-names></string-name>, <string-name><surname>Belhassen</surname> <given-names>S</given-names></string-name>, <string-name><surname>Mourali</surname> <given-names>N</given-names></string-name></person-group>. <article-title>Clinical and prognostic features of a rapidly progressing breast cancer in Tunisia</article-title>. <source>Cancer</source>. <year>1977</year> <month>Jul</month>;<volume>40</volume>(<issue>1</issue>):<fpage>376</fpage>–<lpage>82</lpage>. doi: <pub-id pub-id-type="doi">10.1002/1097-0142(197707)40:1&lt;376::aid-cncr2820400153&gt;3.0.co;2-y</pub-id>. PMID: <pub-id pub-id-type="pmid">880564</pub-id>.</mixed-citation></ref>
<ref id="c69"><label>69.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mabula</surname> <given-names>JB</given-names></string-name>, <string-name><surname>Mchembe</surname> <given-names>MD</given-names></string-name>, <string-name><surname>Chalya</surname> <given-names>PL</given-names></string-name>, <string-name><surname>Giiti</surname> <given-names>G</given-names></string-name>, <string-name><surname>Chandika</surname> <given-names>AB</given-names></string-name>, <string-name><surname>Rambau</surname> <given-names>P</given-names></string-name>, <string-name><surname>Masalu</surname> <given-names>N</given-names></string-name>, <string-name><surname>Gilyomai</surname> <given-names>JM</given-names></string-name></person-group>. <article-title>Stage at diagnosis, clinicopathological and treatment patterns of breast cancer at Bugando Medical Centre in north-western Tanzania</article-title>. <source>Tanzan J Health Res</source>. <year>2012</year> <month>Oct</month>;<volume>14</volume>(<issue>4</issue>):<fpage>269</fpage>–<lpage>79</lpage>. PMID: <pub-id pub-id-type="pmid">26591725</pub-id>.</mixed-citation></ref>
<ref id="c70"><label>70.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><given-names>Ben</given-names> <surname>Gobrane H</surname></string-name>, <string-name><surname>Fakhfakh</surname> <given-names>R</given-names></string-name>, <string-name><surname>Rahal</surname> <given-names>K</given-names></string-name>, <string-name><surname>Ben Ayed</surname> <given-names>F</given-names></string-name>, <string-name><surname>Mâalej</surname> <given-names>M</given-names></string-name>, <string-name><surname>Ben Abdallah</surname> <given-names>M</given-names></string-name>, <string-name><surname>Achour</surname> <given-names>N</given-names></string-name>, <string-name><surname>Hsairi</surname> <given-names>M</given-names></string-name></person-group>. <article-title>Pronostic du cancer du sein à l’Institut de Carcinologie Salah Azaïez de Tunis [Breast cancer prognosis in Salah Azaiez Institute of Cancer, Tunis]</article-title>. <source>East Mediterr Health J</source>. <year>2007</year> <month>Mar</month>- Apr;13(2):309-18. French. PMID: <pub-id pub-id-type="pmid">17684853</pub-id>.</mixed-citation></ref>
<ref id="c71"><label>71.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Weiner</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Mathewos</surname> <given-names>A</given-names></string-name>, <string-name><surname>Addissie</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ayele</surname> <given-names>W</given-names></string-name>, <string-name><surname>Aynalem</surname> <given-names>A</given-names></string-name>, <string-name><surname>Wondemagegnehu</surname> <given-names>T</given-names></string-name>, <string-name><surname>Wienke</surname> <given-names>A</given-names></string-name>, <string-name><surname>Jemal</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Characteristics and follow-up of metastatic breast cancer in Ethiopia: A cohort study of 573 women</article-title>. <source>Breast</source>. <year>2018</year> <month>Dec</month>;<volume>42</volume>:<fpage>23</fpage>–<lpage>30</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.breast.2018.08.095</pub-id>. Epub 2018 Aug 7. PMID: <pub-id pub-id-type="pmid">30149234</pub-id>.</mixed-citation></ref>
<ref id="c72"><label>72.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ersumo</surname> <given-names>T</given-names></string-name>, <string-name><surname>Tamrat</surname> <given-names>G</given-names></string-name>, <string-name><surname>Solomon</surname> <given-names>B</given-names></string-name>, <string-name><surname>Gero</surname> <given-names>T</given-names></string-name></person-group>. <article-title>Breast cancer in a private medical services center: a 10- year experience</article-title>. <source>Ethiopian Medical Journal</source>. <year>2018</year>;<volume>56</volume>(<issue>3</issue>):<fpage>211</fpage>–<lpage>218</lpage>. Available from <ext-link ext-link-type="uri" xlink:href="https://emjema.org/index.php/EMJ/article/view/857">https://emjema.org/index.php/EMJ/article/view/857</ext-link> (accessed 29th November 2024).</mixed-citation></ref>
<ref id="c73"><label>73.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Shiferaw</surname> <given-names>WS</given-names></string-name>, <string-name><surname>Aynalem</surname> <given-names>YA</given-names></string-name>, <string-name><surname>Akalu</surname> <given-names>TY</given-names></string-name>, <string-name><surname>Demelew</surname> <given-names>TM</given-names></string-name></person-group>. <article-title>Incidence and Predictors of Recurrence among Breast Cancer Patients in Black Lion Specialized Hospital Adult Oncology Unit, Addis Ababa, Ethiopia: Retrospective Follow-up Study with Survival Analysis</article-title>. <source>J Cancer Prev</source>. <year>2020</year> <month>Jun</month> 30;<volume>25</volume>(<issue>2</issue>):<fpage>111</fpage>–<lpage>118</lpage>. doi: <pub-id pub-id-type="doi">10.15430/JCP.2020.25.2.111</pub-id>. PMID: <pub-id pub-id-type="pmid">32647652</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC7337003</pub-id>.</mixed-citation></ref>
<ref id="c74"><label>74.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Fouhi</surname> <given-names>ME</given-names></string-name>, <string-name><surname>Mesfioui</surname> <given-names>A</given-names></string-name>, <string-name><surname>Benider</surname> <given-names>A</given-names></string-name></person-group>. <article-title>Male breast cancer: a report of 25 cases</article-title>. <source>Pan Afr Med J</source>. <year>2020</year> Dec 15;<volume>37</volume>:<issue>343</issue>. doi: <pub-id pub-id-type="doi">10.11604/pamj.2020.37.343.23004</pub-id>. PMID: <pub-id pub-id-type="pmid">33738031</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC7934185</pub-id>.</mixed-citation></ref>
<ref id="c75"><label>75.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Abdalla Elhassan</surname> <given-names>SI.</given-names></string-name></person-group> <article-title>The five-year survival rate of breast cancer at Radiation and Isotopes Centre Khartoum, Sudan</article-title>. <source>Heliyon</source>. <year>2020</year> <month>Aug</month> 20;<volume>6</volume>(<issue>8</issue>):<fpage>e04615</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.heliyon.2020.e04615</pub-id>. PMID: <pub-id pub-id-type="pmid">32904288</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC7452576</pub-id>.</mixed-citation></ref>
<ref id="c76"><label>76.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Zingue</surname> <given-names>S</given-names></string-name>, <string-name><surname>Atenguena</surname> <given-names>EO</given-names></string-name>, <string-name><surname>Zingue</surname> <given-names>LL</given-names></string-name>, <string-name><surname>Tueche</surname> <given-names>AB</given-names></string-name>, <string-name><surname>Njamen</surname> <given-names>D</given-names></string-name>, <string-name><surname>Nkoum</surname> <given-names>AB</given-names></string-name>, <string-name><surname>Ndom</surname> <given-names>P</given-names></string-name></person-group>. <article-title>Epidemiological and clinical profile, and survival of patients followed for breast cancer between 2010 and 2015 at the Yaounde General Hospital, Cameroon</article-title>. <source>Pan Afr Med J</source>. <year>2021</year> Jul 7;<volume>39</volume>:<issue>182</issue>. doi: <pub-id pub-id-type="doi">10.11604/pamj.2021.39.182.26866</pub-id>. PMID: <pub-id pub-id-type="pmid">34466203</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC8378266</pub-id>.</mixed-citation></ref>
<ref id="c77"><label>77.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ali-Gombe</surname> <given-names>M</given-names></string-name>, <string-name><surname>Mustapha</surname> <given-names>MI</given-names></string-name>, <string-name><surname>Folasire</surname> <given-names>A</given-names></string-name>, <string-name><surname>Ntekim</surname> <given-names>A</given-names></string-name>, <string-name><surname>Campbell</surname> <given-names>OB</given-names></string-name></person-group>. <article-title>Pattern of survival of breast cancer patients in a tertiary hospital in South West Nigeria</article-title>. <source>Ecancermedicalscience</source>. <year>2021</year> <month>Feb</month> 25;<volume>15</volume>:<elocation-id>1192</elocation-id>. doi: <pub-id pub-id-type="doi">10.3332/ecancer.2021.1192</pub-id>. PMID: <pub-id pub-id-type="pmid">33889201</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC8043689</pub-id>.</mixed-citation></ref>
<ref id="c78"><label>78.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tiruneh</surname> <given-names>M</given-names></string-name>, <string-name><surname>Tesfaw</surname> <given-names>A</given-names></string-name>, <string-name><surname>Tesfa</surname> <given-names>D</given-names></string-name></person-group>. <article-title>Survival and Predictors of Mortality among Breast Cancer Patients in Northwest Ethiopia: A Retrospective Cohort Study</article-title>. <source>Cancer Manag Res</source>. <year>2021</year> <month>Dec</month> 16;<volume>13</volume>:<fpage>9225</fpage>–<lpage>9234</lpage>. doi: <pub-id pub-id-type="doi">10.2147/CMAR.S339988</pub-id>. PMID: <pub-id pub-id-type="pmid">34938122</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC8687444</pub-id>.</mixed-citation></ref>
<ref id="c79"><label>79.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Muddather</surname> <given-names>HF</given-names></string-name>, <string-name><surname>Elhassan</surname> <given-names>MMA</given-names></string-name>, <string-name><surname>Faggad</surname> <given-names>A</given-names></string-name></person-group>. <article-title>Survival Outcomes of Breast Cancer in Sudanese Women: A Hospital-Based Study</article-title>. <source>JCO Glob Oncol</source>. <year>2021</year> <month>Feb</month>;<volume>7</volume>:<fpage>324</fpage>–<lpage>332</lpage>. doi: <pub-id pub-id-type="doi">10.1200/GO.20.00538</pub-id>. PMID: <pub-id pub-id-type="pmid">33617296</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC8081542</pub-id>.</mixed-citation></ref>
<ref id="c80"><label>80.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wambua</surname> <given-names>MD</given-names></string-name>, <string-name><surname>Degu</surname> <given-names>A</given-names></string-name>, <string-name><surname>Tegegne</surname> <given-names>GT</given-names></string-name></person-group>. <article-title>Treatment outcomes and its associated factors among breast cancer patients at Kitui Referral Hospital</article-title>. <source>SAGE Open Med</source>. <year>2022</year> Jan 8;<volume>10</volume>:<issue>20503121211067857</issue>. doi: <pub-id pub-id-type="doi">10.1177/20503121211067857</pub-id>. PMID: <pub-id pub-id-type="pmid">35024144</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC8744162</pub-id>.</mixed-citation></ref>
<ref id="c81"><label>81.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wuraola</surname> <given-names>FO</given-names></string-name>, <string-name><surname>Olasehinde</surname> <given-names>O</given-names></string-name>, <string-name><surname>Di Bernardo</surname> <given-names>M</given-names></string-name>, <string-name><surname>Akinkuolie</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Adisa</surname> <given-names>AO</given-names></string-name>, <string-name><surname>Aderounmu</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Mohammed</surname> <given-names>TO</given-names></string-name>, <string-name><surname>Omoyiola</surname> <given-names>OZ</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Breast cancer in elderly patients: a clinicopathological review of a Nigerian database</article-title>. <source>Ecancermedicalscience</source>. <year>2022</year> <month>Dec</month> 8;<volume>16</volume>:<elocation-id>1484</elocation-id>. doi: <pub-id pub-id-type="doi">10.3332/ecancer.2022.1484</pub-id>. PMID: <pub-id pub-id-type="pmid">36819793</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC9934965</pub-id>.</mixed-citation></ref>
<ref id="c82"><label>82.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Matheka</surname> <given-names>M</given-names></string-name>, <string-name><surname>Mutebi</surname> <given-names>M</given-names></string-name>, <string-name><surname>Sayed</surname> <given-names>S</given-names></string-name>, <string-name><surname>Shah</surname> <given-names>J</given-names></string-name>, <string-name><surname>Shaikh</surname> <given-names>AJ</given-names></string-name></person-group>. <article-title>Metastatic breast cancer in Kenya: survival, prognosis and management at a tertiary referral centre</article-title>. <source>Ecancermedicalscience</source>. <year>2023</year> Jun 27;<volume>17</volume>:<elocation-id>1566</elocation-id>. doi: <pub-id pub-id-type="doi">10.3332/ecancer.2023.1566</pub-id>. PMID: <pub-id pub-id-type="pmid">37396100</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC10310329</pub-id>.</mixed-citation></ref>
<ref id="c83"><label>83.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gnangnon</surname> <given-names>FHR</given-names></string-name>, <string-name><surname>Parenté</surname> <given-names>A</given-names></string-name>, <string-name><surname>Aboubakar</surname> <given-names>M</given-names></string-name>, <string-name><surname>Kiki-Migan</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Totah</surname> <given-names>T</given-names></string-name>, <string-name><surname>Gbessi</surname> <given-names>DG</given-names></string-name>, <string-name><surname>Tonato-Bagnan</surname> <given-names>JA</given-names></string-name>, <string-name><surname>Laleye</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Prognostic factors and overall survival of breast cancer in Benin: a hospital-based study</article-title>. <source>BMC Womens Health</source>. <year>2024</year> May 18;<volume>24</volume>(<issue>1</issue>):<fpage>295</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12905-024-03114-y</pub-id>. PMID: <pub-id pub-id-type="pmid">38762733</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC11102149</pub-id>.</mixed-citation></ref>
<ref id="c84"><label>84.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Soliman</surname> <given-names>M</given-names></string-name></person-group>. <article-title>Squamous cell carcinoma of the breast: A retrospective study</article-title>. <source>J Cancer Res Ther</source>. <year>2019</year> <month>Jul</month>-Sep;15(5):1057-1061. doi: <pub-id pub-id-type="doi">10.4103/jcrt.JCRT_303_17</pub-id>. PMID: <pub-id pub-id-type="pmid">31603110</pub-id>.</mixed-citation></ref>
<ref id="c85"><label>85.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Olasehinde</surname> <given-names>O</given-names></string-name>, <string-name><surname>Alatise</surname> <given-names>O</given-names></string-name>, <string-name><surname>Omisore</surname> <given-names>A</given-names></string-name>, <string-name><surname>Wuraola</surname> <given-names>F</given-names></string-name>, <string-name><surname>Odujoko</surname> <given-names>O</given-names></string-name>, <string-name><surname>Romanoff</surname> <given-names>A</given-names></string-name>, <string-name><surname>Akinkuolie</surname> <given-names>A</given-names></string-name>, <string-name><surname>Arowolo</surname> <given-names>O</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Contemporary management of breast cancer in Nigeria: Insights from an institutional database</article-title>. <source>Int J Cancer</source>. <year>2021</year> <month>Jun</month> 15;<volume>148</volume>(<issue>12</issue>):<fpage>2906</fpage>–<lpage>2914</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ijc.33484</pub-id>. Epub 2021 Feb 9. PMID: <pub-id pub-id-type="pmid">33506499</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC8394611</pub-id>.</mixed-citation></ref>
<ref id="c86"><label>86.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Chokunonga</surname> <given-names>E</given-names></string-name>, <string-name><surname>Borok</surname> <given-names>MZ</given-names></string-name>, <string-name><surname>Chirenje</surname> <given-names>ZM</given-names></string-name>, <string-name><surname>Nyabakau</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Parkin</surname> <given-names>DM</given-names></string-name></person-group>. <article-title>Cancer survival in Harare, Zimbabwe, 1993-1997</article-title>. <source>IARC Sci Publ.</source> <year>2011</year>;(<issue>162</issue>):<fpage>249</fpage>-<lpage>55</lpage>. PMID: <pub-id pub-id-type="pmid">21675430</pub-id>.</mixed-citation></ref>
<ref id="c87"><label>87.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Bah</surname> <given-names>E</given-names></string-name>, <string-name><surname>Sam</surname> <given-names>O</given-names></string-name>, <string-name><surname>Whittle</surname> <given-names>H</given-names></string-name>, <string-name><surname>Ramanakumar</surname> <given-names>A</given-names></string-name>, <string-name><surname>Sankaranarayanan</surname> <given-names>R</given-names></string-name></person-group>. <article-title>Cancer survival in the Gambia, 1993-1997</article-title>. <source>IARC Sci Publ.</source> <year>2011</year>;(<issue>162</issue>):<fpage>97</fpage>-<lpage>100</lpage>. PMID: <pub-id pub-id-type="pmid">21675410</pub-id>.</mixed-citation></ref>
<ref id="c88"><label>88.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Wabinga</surname> <given-names>H</given-names></string-name>, <string-name><surname>Parkin</surname> <given-names>DM</given-names></string-name>, <string-name><surname>Nambooze</surname> <given-names>S</given-names></string-name>, <string-name><surname>Amero</surname> <given-names>J</given-names></string-name></person-group>. <article-title>Cancer survival in Kampala, Uganda, 1993-1997</article-title>. <source>IARC Sci Publ.</source> <year>2011</year>;(<issue>162</issue>):<fpage>243</fpage>-<lpage>7</lpage>. PMID: <pub-id pub-id-type="pmid">21675429</pub-id>.</mixed-citation></ref>
<ref id="c89"><label>89.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Otu</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Ekanem</surname> <given-names>IO</given-names></string-name>, <string-name><surname>Khalil</surname> <given-names>MI</given-names></string-name>, <string-name><surname>Ekpo</surname> <given-names>MD</given-names></string-name>, <string-name><surname>Attah</surname> <given-names>EB</given-names></string-name></person-group>. <article-title>Characterization of breast cancer subgroups in an African population</article-title>. <source>Br J Surg</source>. <year>1989</year> <month>Feb</month>;<volume>76</volume>(<issue>2</issue>):<fpage>182</fpage>–<lpage>4</lpage>. doi: <pub-id pub-id-type="doi">10.1002/bjs.1800760225</pub-id>. PMID: <pub-id pub-id-type="pmid">2702455</pub-id>.</mixed-citation></ref>
<ref id="c90"><label>90.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Okobia</surname> <given-names>MN</given-names></string-name>, <string-name><surname>Osime</surname> <given-names>U</given-names></string-name></person-group>. <article-title>Clinicopathological study of carcinoma of the breast in Benin City</article-title>. <source>Afr J Reprod Health</source>. <year>2001</year> <month>Aug</month>;<volume>5</volume>(<issue>2</issue>):<fpage>56</fpage>–<lpage>62</lpage>. PMID: <pub-id pub-id-type="pmid">12471913</pub-id>.</mixed-citation></ref>
<ref id="c91"><label>91.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Elhaj</surname> <given-names>AM</given-names></string-name>, <string-name><surname>Abdalsalam</surname> <given-names>AI</given-names></string-name>, <string-name><surname>Abuidris</surname> <given-names>AO</given-names></string-name>, <string-name><surname>Eltayeb</surname> <given-names>AA</given-names></string-name></person-group>. <article-title>Overall survival of females with breast cancer in the National Cancer Institute, University of Gezira</article-title>, <source>Sudan. Sudan Medical Monitor</source>. <year>2015</year>;<volume>10</volume>(<issue>1</issue>):<fpage>1</fpage>–<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.4103/1858-5000.157499</pub-id>.</mixed-citation></ref>
<ref id="c92"><label>92.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mensah</surname> <given-names>AC</given-names></string-name>, <string-name><surname>Yarney</surname> <given-names>J</given-names></string-name>, <string-name><surname>Nokoe</surname> <given-names>SK</given-names></string-name>, <string-name><surname>Opoku</surname> <given-names>S</given-names></string-name>, <string-name><surname>Clegg-Lamptey</surname> <given-names>JN</given-names></string-name></person-group>. <article-title>Survival outcomes of breast cancer in Ghana: an analysis of clinicopathological features</article-title>. <source>Open Access Library Journal</source>. <year>2016</year>;<volume>3</volume>(<issue>1</issue>):<fpage>e2145</fpage>. doi: <pub-id pub-id-type="doi">10.4236/oalib.1102145</pub-id>.</mixed-citation></ref>
<ref id="c93"><label>93.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Joko-Fru</surname> <given-names>WY</given-names></string-name>, <string-name><surname>Miranda-Filho</surname> <given-names>A</given-names></string-name>, <string-name><surname>Soerjomataram</surname> <given-names>I</given-names></string-name>, <string-name><surname>Egue</surname> <given-names>M</given-names></string-name>, <string-name><surname>Akele-Akpo</surname> <given-names>MT</given-names></string-name>, <string-name><surname>N’da</surname> <given-names>G</given-names></string-name>, <string-name><surname>Assefa</surname> <given-names>M</given-names></string-name>, <string-name><surname>Buziba</surname> <given-names>N</given-names></string-name>, <string-name><surname>Korir</surname> <given-names>A</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Breast cancer survival in sub-Saharan Africa by age, stage at diagnosis and human development index: A population-based registry study</article-title>. <source>Int J Cancer</source>. <year>2020</year> Mar 1;<volume>146</volume>(<issue>5</issue>):<fpage>1208</fpage>–<lpage>1218</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ijc.32406</pub-id>. Epub 2019 Jun 14. PMID: <pub-id pub-id-type="pmid">31087650</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC7079125</pub-id>.</mixed-citation></ref>
<ref id="c94"><label>94.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Some</surname> <given-names>OR</given-names></string-name>, <string-name><surname>Bague</surname> <given-names>AH</given-names></string-name>, <string-name><surname>Konkobo</surname> <given-names>D</given-names></string-name>, <string-name><surname>Hien</surname> <given-names>D</given-names></string-name>, <string-name><surname>Dembele</surname> <given-names>A</given-names></string-name>, <string-name><surname>Hermann Belemlilga</surname> <given-names>GL</given-names></string-name>, <string-name><surname>Konsegre</surname> <given-names>V</given-names></string-name>, <string-name><surname>Zongo</surname> <given-names>N</given-names></string-name></person-group>. <article-title>Le Cancer du Sein à Bobo-Dioulasso, Burkina Faso: Résultats de la Prise en Charge</article-title>. <source>Oncologie</source>. <year>2022</year>;<volume>24</volume>(<issue>2</issue>):<fpage>173</fpage>–<lpage>184</lpage>. doi: <pub-id pub-id-type="doi">10.32604/oncologie.2022.021250</pub-id>.</mixed-citation></ref>
<ref id="c95"><label>95.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gondos</surname> <given-names>A</given-names></string-name>, <string-name><surname>Brenner</surname> <given-names>H</given-names></string-name>, <string-name><surname>Wabinga</surname> <given-names>H</given-names></string-name>, <string-name><surname>Parkin</surname> <given-names>DM</given-names></string-name></person-group>. <article-title>Cancer survival in Kampala, Uganda</article-title>. <source>Br J Cancer</source>. <year>2005</year> <month>May</month> 9;<volume>92</volume>(<issue>9</issue>):<fpage>1808</fpage>–<lpage>12</lpage>. doi: <pub-id pub-id-type="doi">10.1038/sj.bjc.6602540</pub-id>. PMID: <pub-id pub-id-type="pmid">15827554</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC2362045</pub-id>.</mixed-citation></ref>
<ref id="c96"><label>96.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Traore</surname> <given-names>B</given-names></string-name>, <string-name><surname>Keita</surname> <given-names>M</given-names></string-name>, <string-name><surname>Toure</surname> <given-names>A</given-names></string-name>, <string-name><surname>Camara</surname> <given-names>I</given-names></string-name>, <string-name><surname>Barry</surname> <given-names>A</given-names></string-name>, <string-name><surname>Koulibaly</surname> <given-names>M</given-names></string-name></person-group>. <article-title>Impact of surgery associated with radiotherapy on the prognosis of breast cancer - Guinea Breast Cancer Cohort Study</article-title>. <source>Cancer Rep (Hoboken)</source>. <year>2022</year> <month>Sep</month>;<volume>5</volume>(<issue>9</issue>):<fpage>e1554</fpage>. doi: <pub-id pub-id-type="doi">10.1002/cnr2.1554</pub-id>. Epub 2021 Sep 22. PMID: <pub-id pub-id-type="pmid">34549551</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC9458488</pub-id>.</mixed-citation></ref>
<ref id="c97"><label>97.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Maajani</surname> <given-names>K</given-names></string-name>, <string-name><surname>Jalali</surname> <given-names>A</given-names></string-name>, <string-name><surname>Alipour</surname> <given-names>S</given-names></string-name>, <string-name><surname>Khodadost</surname> <given-names>M</given-names></string-name>, <string-name><surname>Tohidinik</surname> <given-names>HR</given-names></string-name>, <string-name><surname>Yazdani</surname> <given-names>K</given-names></string-name></person-group>. <article-title>The Global and Regional Survival Rate of Women With Breast Cancer: A Systematic Review and Meta-analysis</article-title>. <source>Clin Breast Cancer</source>. <year>2019</year> <month>Jun</month>;<volume>19</volume>(<issue>3</issue>):<fpage>165</fpage>–<lpage>177</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.clbc.2019.01.006</pub-id>. Epub 2019 Jan 29. PMID: <pub-id pub-id-type="pmid">30952546</pub-id>.</mixed-citation></ref>
<ref id="c98"><label>98.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Quang</surname> <given-names>DT</given-names></string-name>, <string-name><surname>Luong Thi</surname> <given-names>T</given-names></string-name>, <string-name><surname>Nguyen Di</surname> <given-names>K</given-names></string-name></person-group>, <article-title>Vu Thi Quynh C, Nguyen Thi Hoa H</article-title>, <source>Phan Ngoc Q. Illuminating the breast cancer survival rates among Southeast Asian women: A systematic review and meta-analysis spanning four decades. Curr Probl Cancer</source>. <year>2024</year> <month>Feb</month>;<volume>48</volume>:<issue>101062</issue>. doi: <pub-id pub-id-type="doi">10.1016/j.currproblcancer.2024.101062</pub-id>. Epub 2024 Feb 2. PMID: <pub-id pub-id-type="pmid">38309146</pub-id>.</mixed-citation></ref>
<ref id="c99"><label>99.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Maajani</surname> <given-names>K</given-names></string-name>, <string-name><surname>Khodadost</surname> <given-names>M</given-names></string-name>, <string-name><surname>Fattahi</surname> <given-names>A</given-names></string-name>, <string-name><surname>Pirouzi</surname> <given-names>A</given-names></string-name></person-group>. <article-title>Survival rates of patients with breast cancer in countries in the Eastern Mediterranean Region: a systematic review and meta-analysis</article-title>. <source>East Mediterr Health J</source>. <year>2020</year> <month>Feb</month> 24;<volume>26</volume>(<issue>2</issue>):<fpage>219</fpage>–<lpage>232</lpage>. doi: <pub-id pub-id-type="doi">10.26719/2020.26.2.219</pub-id>. PMID: <pub-id pub-id-type="pmid">32141601</pub-id>.</mixed-citation></ref>
<ref id="c100"><label>100.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gómez-Raposo</surname> <given-names>C</given-names></string-name>, <string-name><surname>Zambrana Tévar</surname> <given-names>F</given-names></string-name>, <string-name><surname>Sereno Moyano</surname> <given-names>M</given-names></string-name>, <string-name><surname>López Gómez</surname> <given-names>M</given-names></string-name>, <string-name><surname>Casado</surname> <given-names>E.</given-names></string-name></person-group> <article-title>Male breast cancer</article-title>. <source>Cancer Treat Rev</source>. <year>2010</year> Oct;<volume>36</volume>(<issue>6</issue>):<fpage>451</fpage>–<lpage>7</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.ctrv.2010.02.002</pub-id>. Epub 2010 Mar 2. PMID: <pub-id pub-id-type="pmid">20193984</pub-id>.</mixed-citation></ref>
<ref id="c101"><label>101.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Scomersi</surname> <given-names>S</given-names></string-name>, <string-name><surname>Giudici</surname> <given-names>F</given-names></string-name>, <string-name><surname>Cacciatore</surname> <given-names>G</given-names></string-name>, <string-name><surname>Losurdo</surname> <given-names>P</given-names></string-name>, <string-name><surname>Fracon</surname> <given-names>S</given-names></string-name>, <string-name><surname>Cortinovis</surname> <given-names>S</given-names></string-name>, <string-name><surname>Ceccherini</surname> <given-names>R</given-names></string-name>, <string-name><surname>Zanconati</surname> <given-names>F</given-names></string-name>, <string-name><surname>Tonutti</surname> <given-names>M</given-names></string-name>, <string-name><surname>Bortul</surname> <given-names>M</given-names></string-name></person-group>. <article-title>Comparison between male and female breast cancer survival using propensity score matching analysis</article-title>. <source>Sci Rep</source>. <year>2021</year> Jun 2;<volume>11</volume>(<issue>1</issue>):<fpage>11639</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-021-91131-4</pub-id>. PMID: <pub-id pub-id-type="pmid">34079019</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC8172634</pub-id>.</mixed-citation></ref>
<ref id="c102"><label>102.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gwark</surname> <given-names>S</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>J</given-names></string-name>, <string-name><surname>Chung</surname> <given-names>IY</given-names></string-name>, <string-name><surname>Kim</surname> <given-names>HJ</given-names></string-name>, <string-name><surname>Ko</surname> <given-names>BS</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>JW</given-names></string-name>, <string-name><surname>Son</surname> <given-names>BH</given-names></string-name>, <string-name><surname>Ahn</surname> <given-names>SH</given-names></string-name>, <string-name><surname>Lee</surname> <given-names>SB</given-names></string-name></person-group>. <article-title>Survival pattern in male breast cancer: distinct from female breast cancer</article-title>. <source>Front Oncol</source>. <year>2024</year> <month>Jun</month> 28;<volume>14</volume>:<issue>1392592</issue>. doi: <pub-id pub-id-type="doi">10.3389/fonc.2024.1392592</pub-id>. PMID: <pub-id pub-id-type="pmid">39007102</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC11239393</pub-id>.</mixed-citation></ref>
<ref id="c103"><label>103.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Miao</surname> <given-names>H</given-names></string-name>, <string-name><surname>Verkooijen</surname> <given-names>HM</given-names></string-name>, <string-name><surname>Chia</surname> <given-names>KS</given-names></string-name>, <string-name><surname>Bouchardy</surname> <given-names>C</given-names></string-name>, <string-name><surname>Pukkala</surname> <given-names>E</given-names></string-name>, <string-name><surname>Larønningen</surname> <given-names>S</given-names></string-name>, <string-name><surname>Mellemkjær</surname> <given-names>L</given-names></string-name>, <string-name><surname>Czene</surname> <given-names>K</given-names></string-name>, <string-name><surname>Hartman</surname> <given-names>M</given-names></string-name></person-group>. <article-title>Incidence and outcome of male breast cancer: an international population-based study</article-title>. <source>J Clin Oncol</source>. <year>2011</year> <month>Nov</month> 20;<volume>29</volume>(<issue>33</issue>):<fpage>4381</fpage>–<lpage>6</lpage>. doi: <pub-id pub-id-type="doi">10.1200/JCO.2011.36.8902</pub-id>. Epub 2011 Oct 3. PMID: <pub-id pub-id-type="pmid">21969512</pub-id>.</mixed-citation></ref>
<ref id="c104"><label>104.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Varzaru</surname> <given-names>VB</given-names></string-name>, <string-name><surname>Anastasiu-Popov</surname> <given-names>DM</given-names></string-name>, <string-name><surname>Eftenoiu</surname> <given-names>AE</given-names></string-name>, <string-name><surname>Popescu</surname> <given-names>R</given-names></string-name>, <string-name><surname>Vlad</surname> <given-names>DC</given-names></string-name>, <string-name><surname>Vlad</surname> <given-names>CS</given-names></string-name>, <string-name><surname>Moatar</surname> <given-names>AE</given-names></string-name>, <string-name><surname>Puscasiu</surname> <given-names>D</given-names></string-name>, <string-name><surname>Cobec</surname> <given-names>IM</given-names></string-name></person-group>. <article-title>Observational Study of Men and Women with Breast Cancer in Terms of Overall Survival</article-title>. <source>Cancers (Basel)</source>. <year>2024</year> Sep 1;<volume>16</volume>(<issue>17</issue>):<fpage>3049</fpage>. doi: <pub-id pub-id-type="doi">10.3390/cancers16173049</pub-id>. PMID: <pub-id pub-id-type="pmid">39272907</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC11394319</pub-id>.</mixed-citation></ref>
<ref id="c105"><label>105.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Carey</surname> <given-names>LA</given-names></string-name>, <string-name><surname>Perou</surname> <given-names>CM</given-names></string-name>, <string-name><surname>Livasy</surname> <given-names>CA</given-names></string-name>, <string-name><surname>Dressler</surname> <given-names>LG</given-names></string-name>, <string-name><surname>Cowan</surname> <given-names>D</given-names></string-name>, <string-name><surname>Conway</surname> <given-names>K</given-names></string-name>, <string-name><surname>Karaca</surname> <given-names>G</given-names></string-name>, <string-name><surname>Troester</surname> <given-names>MA</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study</article-title>. <source>JAMA</source>. <year>2006</year> <month>Jun</month> 7;<volume>295</volume>(<issue>21</issue>):<fpage>2492</fpage>–<lpage>502</lpage>. doi: <pub-id pub-id-type="doi">10.1001/jama.295.21.2492</pub-id>. PMID: <pub-id pub-id-type="pmid">16757721</pub-id>.</mixed-citation></ref>
<ref id="c106"><label>106.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Gradishar</surname> <given-names>WJ</given-names></string-name>, <string-name><surname>Moran</surname> <given-names>MS</given-names></string-name>, <string-name><surname>Abraham</surname> <given-names>J</given-names></string-name>, <string-name><surname>Aft</surname> <given-names>R</given-names></string-name>, <string-name><surname>Agnese</surname> <given-names>D</given-names></string-name>, <string-name><surname>Allison</surname> <given-names>KH</given-names></string-name>, <string-name><surname>Blair</surname> <given-names>SL</given-names></string-name>, <string-name><surname>Burstein</surname> <given-names>HJ</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>NCCN Guidelines® Insights: Breast Cancer, Version 4.2021</article-title>. <source>J Natl Compr Canc Netw</source>. <year>2021</year> May 1;<volume>19</volume>(<issue>5</issue>):<fpage>484</fpage>–<lpage>493</lpage>. doi: <pub-id pub-id-type="doi">10.6004/jnccn.2021.0023</pub-id>. PMID: <pub-id pub-id-type="pmid">34794122</pub-id>.</mixed-citation></ref>
<ref id="c107"><label>107.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Morris</surname> <given-names>GJ</given-names></string-name>, <string-name><surname>Mitchell</surname> <given-names>EP</given-names></string-name></person-group>. <article-title>Higher incidence of aggressive breast cancers in African-American women: a review</article-title>. <source>J Natl Med Assoc</source>. <year>2008</year> <month>Jun</month>;<volume>100</volume>(<issue>6</issue>):<fpage>698</fpage>–<lpage>702</lpage>. doi: <pub-id pub-id-type="doi">10.1016/s0027-9684(15)31344-4</pub-id>. PMID: <pub-id pub-id-type="pmid">18595572</pub-id>.</mixed-citation></ref>
<ref id="c108"><label>108.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Al-Mahmood</surname> <given-names>S</given-names></string-name>, <string-name><surname>Sapiezynski</surname> <given-names>J</given-names></string-name>, <string-name><surname>Garbuzenko</surname> <given-names>OB</given-names></string-name>, <string-name><surname>Minko</surname> <given-names>T</given-names></string-name></person-group>. <article-title>Metastatic and triple-negative breast cancer: challenges and treatment options</article-title>. <source>Drug Deliv Transl Res</source>. <year>2018</year> <month>Oct</month>;<volume>8</volume>(<issue>5</issue>):<fpage>1483</fpage>–<lpage>1507</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s13346-018-0551-3</pub-id>. PMID: <pub-id pub-id-type="pmid">29978332</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC6133085</pub-id>.</mixed-citation></ref>
<ref id="c109"><label>109.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Podo</surname> <given-names>F</given-names></string-name>, <string-name><surname>Buydens</surname> <given-names>LM</given-names></string-name>, <string-name><surname>Degani</surname> <given-names>H</given-names></string-name>, <string-name><surname>Hilhorst</surname> <given-names>R</given-names></string-name>, <string-name><surname>Klipp</surname> <given-names>E</given-names></string-name>, <string-name><surname>Gribbestad</surname> <given-names>IS</given-names></string-name>, <string-name><surname>Van Huffel</surname> <given-names>S</given-names></string-name>, <string-name><surname>van Laarhoven</surname> <given-names>HW</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Triple-negative breast cancer: present challenges and new perspectives</article-title>. <source>Mol Oncol</source>. <year>2010</year> <month>Jun</month>;<volume>4</volume>(<issue>3</issue>):<fpage>209</fpage>–<lpage>29</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.molonc.2010.04.006</pub-id>. Epub 2010 Apr 24. PMID: <pub-id pub-id-type="pmid">20537966</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC5527939</pub-id>.</mixed-citation></ref>
<ref id="c110"><label>110.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Martini</surname> <given-names>R</given-names></string-name>, <string-name><surname>Chen</surname> <given-names>Y</given-names></string-name>, <string-name><surname>Jenkins</surname> <given-names>BD</given-names></string-name>, <string-name><surname>Elhussin</surname> <given-names>IA</given-names></string-name>, <string-name><surname>Cheng</surname> <given-names>E</given-names></string-name>, <string-name><surname>Hoda</surname> <given-names>SA</given-names></string-name>, <string-name><surname>Ginter</surname> <given-names>PS</given-names></string-name>, <string-name><surname>Hanover</surname> <given-names>J</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Investigation of triple-negative breast cancer risk alleles in an International African-enriched cohort</article-title>. <source>Sci Rep</source>. <year>2021</year> Apr 29;<volume>11</volume>(<issue>1</issue>):<fpage>9247</fpage>. doi: <pub-id pub-id-type="doi">10.1038/s41598-021-88613-w</pub-id>. PMID: <pub-id pub-id-type="pmid">33927264</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC8085076</pub-id>.</mixed-citation></ref>
<ref id="c111"><label>111.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Koon Sun Pat</surname> <given-names>M</given-names></string-name>, <string-name><surname>Manraj</surname> <given-names>M</given-names></string-name>, <string-name><surname>Manraj</surname> <given-names>S.</given-names></string-name></person-group> <article-title>Breast cancer survival analysis in the Republic of Mauritius by age, stage at diagnosis and molecular subtype: A retrospective cohort study</article-title>. <source>Int J Cancer</source>. <year>2025</year> Jan 15;<volume>156</volume>(<issue>2</issue>):<fpage>331</fpage>–<lpage>338</lpage>. doi: <pub-id pub-id-type="doi">10.1002/ijc.35172</pub-id>. Epub 2024 Sep 7. PMID: <pub-id pub-id-type="pmid">39243396</pub-id>.</mixed-citation></ref>
<ref id="c112"><label>112.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Sanyang</surname> <given-names>O</given-names></string-name>, <string-name><surname>Lopez-Verdugo</surname> <given-names>F</given-names></string-name>, <string-name><surname>Mali</surname> <given-names>M</given-names></string-name>, <string-name><surname>Moustafa</surname> <given-names>M</given-names></string-name>, <string-name><surname>Nellermoe</surname> <given-names>J</given-names></string-name>, <string-name><surname>Sorensen</surname> <given-names>J</given-names></string-name>, <string-name><surname>Bittaye</surname> <given-names>M</given-names></string-name>, <string-name><surname>Njie</surname> <given-names>R</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Geospatial analysis and impact of targeted development of breast cancer care in The Gambia: a cross-sectional study</article-title>. <source>BMC Health Serv Res</source>. <year>2021</year> Sep 9;<volume>21</volume>(<issue>1</issue>):<fpage>943</fpage>. doi: <pub-id pub-id-type="doi">10.1186/s12913-021-06963-7</pub-id>. PMID: <pub-id pub-id-type="pmid">34503503</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC8428029</pub-id>.</mixed-citation></ref>
<ref id="c113"><label>113.</label><mixed-citation publication-type="report"><person-group person-group-type="author"><collab>World Health Organization</collab></person-group>. <source>Atlas of African Health Statistics 2022: Health situation analysis of the WHO African Region — Country profiles. Brazzaville: WHO Regional Office for Africa</source>. <year>2022</year> [online]. Available from <ext-link ext-link-type="uri" xlink:href="https://www.afro.who.int/publications/atlas-african-health-statistics-2022-health-situation-analysis-who-african-region-0">https://www.afro.who.int/publications/atlas-african-health-statistics-2022-health-situation-analysis-who-african-region-0</ext-link> (accessed 30th November 2024).</mixed-citation></ref>
<ref id="c114"><label>114.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Lombe</surname> <given-names>DC</given-names></string-name>, <string-name><surname>Mwamba</surname> <given-names>M</given-names></string-name>, <string-name><surname>Msadabwe</surname> <given-names>S</given-names></string-name>, <string-name><surname>Bond</surname> <given-names>V</given-names></string-name>, <string-name><surname>Simwinga</surname> <given-names>M</given-names></string-name>, <string-name><surname>Ssemata</surname> <given-names>AS</given-names></string-name>, <string-name><surname>Muhumuza</surname> <given-names>R</given-names></string-name>, <string-name><surname>Seeley</surname> <given-names>J</given-names></string-name>, <string-name><surname>Mwaka</surname> <given-names>AD</given-names></string-name>, <etal>et al.</etal></person-group> <article-title>Delays in seeking, reaching and access to quality cancer care in sub-Saharan Africa: a systematic review</article-title>. <source>BMJ Open</source>. <year>2023</year> Apr 13;<volume>13</volume>(<issue>4</issue>):<fpage>e067715</fpage>. doi: <pub-id pub-id-type="doi">10.1136/bmjopen-2022-067715</pub-id>. PMID: <pub-id pub-id-type="pmid">37055211</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC10106057</pub-id>.</mixed-citation></ref>
<ref id="c115"><label>115.</label><mixed-citation publication-type="report"><person-group person-group-type="author"><string-name><surname>Round</surname> <given-names>JI.</given-names></string-name></person-group> <source>Globalization, Growth, Inequality and Poverty in Africa: A Macroeconomic Perspective</source>. Research Paper 2007/055 <publisher-name>Helsinki: UNU-WIDER</publisher-name>. <year>2007</year> [online]. Available from <ext-link ext-link-type="uri" xlink:href="https://www.wider.unu.edu/publication/globalization-growth-inequality-and-poverty-africa">https://www.wider.unu.edu/publication/globalization-growth-inequality-and-poverty-africa</ext-link> (accessed 30th November 2024).</mixed-citation></ref>
<ref id="c116"><label>116.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Ichoku</surname> <given-names>HE</given-names></string-name>, <string-name><surname>Mooney</surname> <given-names>G</given-names></string-name>, <string-name><surname>Ataguba</surname> <given-names>JE</given-names></string-name></person-group>. <article-title>Africanizing the social determinants of health: embedded structural inequalities and current health outcomes in sub-Saharan Africa</article-title>. <source>Int J Health Serv</source>. <year>2013</year>;<volume>43</volume>(<issue>4</issue>):<fpage>745</fpage>–<lpage>59</lpage>. doi: <pub-id pub-id-type="doi">10.2190/HS.43.4.i</pub-id>. PMID: <pub-id pub-id-type="pmid">24397237</pub-id>.</mixed-citation></ref>
<ref id="c117"><label>117.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>James</surname> <given-names>PB</given-names></string-name>, <string-name><surname>Asiimwe</surname> <given-names>JB</given-names></string-name>, <string-name><surname>Wardle</surname> <given-names>J</given-names></string-name>, <string-name><surname>Mwaka</surname> <given-names>AD</given-names></string-name>, <string-name><surname>Kasilo</surname> <given-names>OMJ</given-names></string-name></person-group>. <article-title>African culture, traditional medicine, and cancer care</article-title>. <source>Lancet Oncol</source>. <year>2022</year> <month>Jun</month>;<volume>23</volume>(<issue>6</issue>):<fpage>705</fpage>–<lpage>706</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S1470-2045(22)00157-7</pub-id>. Epub 2022 May 9. PMID: <pub-id pub-id-type="pmid">35550271</pub-id>.</mixed-citation></ref>
<ref id="c118"><label>118.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Tetteh</surname> <given-names>DA</given-names></string-name>, <string-name><surname>Faulkner</surname> <given-names>SL</given-names></string-name></person-group>. <article-title>Sociocultural factors and breast cancer in sub-Saharan Africa: implications for diagnosis and management</article-title>. <source>Womens Health (Lond)</source>. <year>2016</year> <month>Jan</month>;<volume>12</volume>(<issue>1</issue>):<fpage>147</fpage>–<lpage>56</lpage>. doi: <pub-id pub-id-type="doi">10.2217/whe.15.76</pub-id>. Epub 2016 Jan 12. PMID: <pub-id pub-id-type="pmid">26757491</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC5779571</pub-id>.</mixed-citation></ref>
<ref id="c119"><label>119.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Mansour</surname> <given-names>R</given-names></string-name>, <string-name><surname>Abdel-Razeq</surname> <given-names>H</given-names></string-name>, <string-name><surname>Al-Hussaini</surname> <given-names>M</given-names></string-name>, <string-name><surname>Shamieh</surname> <given-names>O</given-names></string-name>, <string-name><surname>Al-Ibraheem</surname> <given-names>A</given-names></string-name>, <string-name><surname>Al-Omari</surname> <given-names>A</given-names></string-name>, <string-name><surname>Mansour</surname> <given-names>AH</given-names></string-name></person-group>. <article-title>Systemic Barriers to Optimal Cancer Care in Resource-Limited Countries: Jordanian Healthcare as an Example</article-title>. <source>Cancers (Basel)</source>. <year>2024</year> Mar 11;<volume>16</volume>(<issue>6</issue>):<fpage>1117</fpage>. doi: <pub-id pub-id-type="doi">10.3390/cancers16061117</pub-id>. PMID: <pub-id pub-id-type="pmid">38539452</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC10968872</pub-id>.</mixed-citation></ref>
<ref id="c120"><label>120.</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><string-name><surname>Jedy-Agba</surname> <given-names>E</given-names></string-name>, <string-name><surname>McCormack</surname> <given-names>V</given-names></string-name>, <string-name><surname>Adebamowo</surname> <given-names>C</given-names></string-name>, <string-name><surname>Dos-Santos-Silva</surname> <given-names>I</given-names></string-name></person-group>. <article-title>Stage at diagnosis of breast cancer in sub-Saharan Africa: a systematic review and meta-analysis</article-title>. <source>Lancet Glob Health</source>. <year>2016</year> <month>Dec</month>;<volume>4</volume>(<issue>12</issue>):<fpage>e923</fpage>–<lpage>e935</lpage>. doi: <pub-id pub-id-type="doi">10.1016/S2214-109X(16)30259-5</pub-id>. PMID: <pub-id pub-id-type="pmid">27855871</pub-id>; PMCID: <pub-id pub-id-type="pmcid">PMC5708541</pub-id>.</mixed-citation></ref>
</ref-list>
</back>
<sub-article id="sa0" article-type="editor-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.105488.1.sa3</article-id>
<title-group>
<article-title>eLife Assessment</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Yang</surname>
<given-names>Yongliang</given-names>
</name>
<role specific-use="editor">Reviewing Editor</role>
<aff>
<institution-wrap>
<institution>Dalian University of Technology</institution>
</institution-wrap>
<city>Dalian</city>
<country>China</country>
</aff>
</contrib>
</contrib-group>
<kwd-group kwd-group-type="evidence-strength">
<kwd>Solid</kwd>
</kwd-group>
<kwd-group kwd-group-type="claim-importance">
<kwd>Valuable</kwd>
</kwd-group>
</front-stub>
<body>
<p>This study presents a <bold>valuable</bold> meta-analysis that highlights low and highly variable breast cancer survival rates across Africa, emphasizing the pressing need for public health in Africa. The evidence supporting the claims of the authors is <bold>solid</bold>, although a clarification of the crude 5-year survival rates would have strengthened the study. The work will be of interest to scientists working in the field of public health and breast cancer.</p>
</body>
</sub-article>
<sub-article id="sa1" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.105488.1.sa2</article-id>
<title-group>
<article-title>Reviewer #1 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>This meta-analysis synthesized data from 79 studies across 22 African countries, encompassing over 27,000 breast cancer patients, to estimate 5-year survival rates. The pooled survival rate was 48%, with substantial regional variation, ranging from 64% in Northern Africa to 32% in Western Africa. Survival outcomes were associated with socioeconomic indicators such as education level, Human Development Index (HDI), and Socio-demographic Index (SDI). Although no significant differences in survival were observed between sexes, non-Black Africans had better outcomes. Despite global advances in cancer care, breast cancer survival in Africa has largely stagnated since the early 2010s, underscoring the need for improved healthcare infrastructure, early detection, and equitable access to treatment.</p>
<p>Strengths:</p>
<p>The study has several strengths. It features a comprehensive literature search, adherence to the PRISMA reporting guideline, and prospective registration on PROSPERO, including documentation of protocol deviations. The authors employed rigorous meta-analytic techniques, including subgroup analyses and meta-regression, allowing for a nuanced investigation of potential effect modifiers.</p>
<p>Weaknesses:</p>
<p>Analyses of crude 5-year survival rates are inherently difficult to interpret, particularly in the absence of key clinical variables such as stage at diagnosis or whether cancers were detected through screening programs. This omission raises concerns about lead time bias, where earlier diagnosis (e.g., via screening) may falsely appear to improve survival without affecting actual mortality. The higher survival seen in North Africa, for example, may reflect earlier diagnosis rather than improved prognosis or care quality. In this context, the age of the study population is another important aspect.</p>
<p>Relatedly, the representativeness of the included study populations is unclear. The data sources for individual studies - whether from national cancer registries or single tertiary hospitals -are not systematically reported. This distinction is crucial, as survival outcomes differ significantly between population-based and hospital-based cohorts. Without this contextual information, the generalizability of the findings is limited.</p>
<p>The meta-regression analyses further raise concerns. The authors use study-level covariates (e.g., national HDI, average years of schooling) to explain variation in survival, yet they do not acknowledge the risk of ecological bias. Inferring individual-level effects from aggregated data is methodologically flawed, and the authors' causal interpretation of these associations is inappropriate, especially given the potential for confounding by unmeasured variables at both the individual and study levels.</p>
<p>The assessment of publication bias is similarly problematic. While funnel plot asymmetry and a significant Egger's test are interpreted as evidence of bias, such methods are unreliable in meta-analyses of observational studies. Smaller studies may differ meaningfully from larger ones, not due to selective reporting, but because they may recruit patients from specialized tertiary centers where outcomes are poorer. The observed relationship between study size and survival may therefore reflect true differences in patient populations, not publication bias.</p>
<p>Despite claiming to search for gray literature via Google Scholar, no such studies appear in the PRISMA flowchart. This is a missed opportunity. Gray literature - especially reports from cancer registries - could have enhanced the quality and completeness of the data. While cancer registration systems are not available in all African countries, several do exist, and the authors should have made greater efforts to incorporate routine surveillance data where available. Mortality data from vital statistics systems, available in some countries, could also have provided useful context or validation.</p>
<p>The study's approach to quality assessment is limited. The scoring tool, adapted from Ssentongo et al., conflates completeness of reporting with risk of bias and fails to address key domains such as study population representativeness, selection bias, and lead time bias. Rather than calculating an overall quality score, the authors should have used a structured tool that evaluates risk of bias across defined domains-such as ROBINS-I, ROBINS-E, or tools developed for prevalence studies (e.g., Tonia et al., BMJ Mental Health, 2023). Cochrane guidance and the textbook by Egger, Higgins, and Davey Smith (DOI:10.1002/9781119099369) provide valuable resources for this purpose.</p>
<p>The cumulative meta-analysis is not particularly informative, considering the massive heterogeneity in survival rates. It would be more meaningful to stratify the analysis by calendar period. In general, with such important heterogeneity, the calculation of an overall estimate does not add much.</p>
<p>The authors spend quite some time discussing differences in survival between men and women and between the current and the 2018 estimates, despite the fact that the survival rates are similar, with widely overlapping confidence intervals. The use of a Z-test in this context is inappropriate as it ignores the heterogeneity between studies.</p>
<p>Minor point:</p>
<p>The terms retrospective and prospective are not particularly helpful - every longitudinal study of survival is retrospective. What the authors mean is whether or not the data were collected within a study designed to address this question, or whether existing data were used that were collected for another purpose. See also DOI: 10.1136/bmj.302.6771.249.</p>
</body>
</sub-article>
<sub-article id="sa2" article-type="referee-report">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.105488.1.sa1</article-id>
<title-group>
<article-title>Reviewer #2 (Public review):</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<anonymous/>
<role specific-use="referee">Reviewer</role>
</contrib>
</contrib-group>
</front-stub>
<body>
<p>Summary:</p>
<p>The study provides an updated literature review and meta-analysis for the 5-year survival estimates in breast cancer patients across continental Africa. The findings reveal substantial disparities between regions and other factors, highlighting the disadvantaged areas in Africa and the urgent need to address these inequities across the continent.</p>
<p>Strengths:</p>
<p>The main strengths of this study include:</p>
<p>
(1) the thorough literature search with an increasing number of included studies that enhances result reliability;</p>
<p>
(2) standard and appropriate statistical methods with clear reporting;</p>
<p>
(3) a comprehensive discussion.</p>
<p>Overall, the paper is well-structured, clearly presented, and provides useful insights.</p>
<p>Weaknesses:</p>
<p>However, I have a few concerns that I would like the authors to address.</p>
<p>(1) The conclusion &quot;A country-wise comparison with 2018 estimates suggests a declining survival tendency, with WHO AFRO countries reporting the poorest estimates among other WHO regions.&quot; appears to have been drawn from the comparisons across both different regions and different time periods, which is incorrect! As shown in Figure 8, survival in Africa has increased from below 30% (WHO AFRO 2017) to around 50% (AFRICA 2024, presumably the current study). Section 3.5 is confusing and headed in the wrong direction. The key message in Figure 8 is that the current survival estimate in Africa is still lower than that of other WHO regions from a few years ago, highlighting the urgent need to improve survival in Africa.</p>
<p>(2) The previous review by Ssentongo et al. classified countries into North Africa and sub-Saharan Africa (SSA), regions divided by the Sahara Desert. This classification is not only geographical-based, but also accounts for the significant differences in ethnicity, health system, and socioeconomic factors. North Africa (especially Egypt, Tunisia, Morocco) has better cancer registries, earlier detection, more treatment access, and therefore better survival outcomes (as shown in Figure 2). SSA tends to have worse outcomes, due to later-stage diagnosis, limited pathology, and access barriers. Given that the survival in women with breast cancer is among the lowest for several SSA countries, the study would benefit from an additional comparison between pooled estimates of North African and SSA, and comparisons with previous pooled estimates.</p>
<p>(3) The authors classified studies under the female group. Females constituted at least 80% of the sample population, and subgroup analysis revealed only a marginal discrepancy in survival rates between the two sexes. However, most of the breast cancer patients and related studies consist predominantly of females. Given the non-negligible differences in various aspects between females and males, sensitivity analyses restricted to studies among females (as in Figure 2-3) would be informative for future research in breast cancer patients.</p>
<p>(4) Stage at diagnosis and treatment are the strongest prognostic factors for breast cancer survival. Though data regarding these variables are not available for all studies, and it's complicated to compare or pool the results from different studies (as mentioned in the limitation), could the authors perform the regression analyses regarding early vs. late stages, and the percentage of treatment received? These two factors are too significant to overlook in studies on breast cancer survival.</p>
<p>(5) The authors reported that studies published before 2019 had a higher survival than those conducted from 2019 onwards, which could be misleading and requires further explanation. As the authors noted ─&quot;the year of publication may not be a reliable measure of the effect in question&quot;─ a better approach would be to use the year of inclusion, i.e., the year the studies were conducted.</p>
<p>(6) Northern and Western Africa both have the highest incidence of breast cancer in Africa, yet their 5-year survival estimates differ substantially. However, the authors have discussed the survival disparities without considering their similarly higher incidence rates. Could this disparity reflect different contributing factors, with the higher incidence rate in Northern Africa resulting from better screening programs (leading to more detections), while that in Western Africa stems from other epidemiological factors despite lower screening participation? Though the incidence rate is not the primary focus of this study, briefly exploring this dichotomy would enhance the discussion and provide valuable insights for readers.</p>
</body>
</sub-article>
<sub-article id="sa3" article-type="author-comment">
<front-stub>
<article-id pub-id-type="doi">10.7554/eLife.105488.1.sa0</article-id>
<title-group>
<article-title>Author response:</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Badu-Peprah</surname>
<given-names>Augustina</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kontor</surname>
<given-names>Ernest Kissi</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0001-7349-8012</contrib-id></contrib>
<contrib contrib-type="author">
<name>
<surname>Benjamin</surname>
<given-names>Adu-Gyamfi</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kumah</surname>
<given-names>Jessica</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Essuman</surname>
<given-names>Akosua Aya</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Selorm</surname>
<given-names>Bossoh</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Nurudeen</surname>
<given-names>Issahak</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Owusu</surname>
<given-names>Bismark Osei</given-names>
</name>
<role specific-use="author">Author</role>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jain</surname>
<given-names>Nityanand</given-names>
</name>
<role specific-use="author">Author</role>
<contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-7918-7909</contrib-id></contrib>
</contrib-group>
</front-stub>
<body>
<p>We thank the reviewing editors, senior editors, and reviewers for their time, efforts, and constructive feedback. We believe the points raised are addressable and we would like to proceed with a revised submission for further review. Specifically, we plan the following revisions:</p>
<p>Editor’s Comments</p>
<p>We will clarify study definitions to ensure the meaning of &quot;5-year crude overall survival time&quot; is explicit for readers.</p>
<p>Reviewer 1 Comments</p>
<p>- Clarify and supplement the work with detailed sources of study origin (cancer registries or single-center cohorts).</p>
<p>- Conduct a multi-level hierarchical meta-analysis to address concerns of ecological fallacy in interpreting results.</p>
<p>- Perform an ecological sensitivity analysis and clarify findings regarding small study effects.</p>
<p>- Expand the search base significantly by including African local databases; preliminary searches have identified over 50 potentially eligible doctoral theses, dissertations, local journal articles, and gray literature, potentially adding data from five or more additional countries.</p>
<p>Reviewer 2 Comments</p>
<p>- Conduct subgroup analyses by sex and assess the influence of the percentage of males in mixed cohorts.</p>
<p>- Enhance the limited meta-analysis and provide supplementary full forest plots for all analyses.</p>
<p>- Clarify phrasing in sections identified by the reviewer.</p>
<p>Additional Planned Clarifications and Analyses</p>
<p>- Elucidate the role of cumulative meta-analysis in mitigating lead-time bias.</p>
<p>- Include supplementary cumulative meta-analysis based on the year of investigation (instead of publication year).</p>
<p>- Perform subgroup analyses by clinical staging, TNM grading, and treatment modalities where data from ≥10 studies is available.</p>
<p>- Expand discussion on the merits of quality assessment versus risk of bias evaluation in large scale epidemiological and observational studies, in line with other studies of this scale.</p>
<p>- Condense the comparison with 2018 estimates, as per reviewer suggestions.</p>
<p>Clarification Regarding SSA vs. AU Classification</p>
<p>We do not intend to compare survival between &quot;Sub-Saharan Africa&quot; (SSA) and North Africa, as this binary classification is historically rooted and does not reflect current African Union (AU) administrative or policy groupings. Our regional analyses will adhere to the AU’s contemporary regional framework to better reflect political, cultural, and healthcare system realities.</p>
<p>On Registry Data</p>
<p>We will clarify that we will not extract raw registry data, as such data is typically unprocessed and does not provide 5-year overall survival metrics. As such extracting raw, individual-level data from registries or vital statistics systems falls outside the methodological scope of a meta-analysis. Meta-analyses are designed to synthesize published survival estimates or those available from reports where survival analyses have already been conducted. Utilizing raw surveillance data would require primary data processing and survival analysis — effectively creating new data, not synthesizing existing results. This would represent a distinct study design, such as a pooled analysis or original cohort study, rather than a meta-analysis. Where registry reports present summary survival estimates (e.g., 5-year overall survival) in a format compatible with meta-analysis, we will certainly include them.</p>
<p>All planned additional analyses will depend on data quality, consistency, and feasibility for pooling using state-of-the-art statistical techniques. Where pooling is not possible, we will transparently report limitations.</p>
</body>
</sub-article>
</article>